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 ABSTRACT 
The overarching goal of this dissertation was to elucidate the psychosocial and behavioral 
determinants of medication nonadherence among African Americans with hypertension.  One in 
three Americans in the United States has hypertension, and the prevalence of hypertension 
among African Americans is among the highest in the world.  In addition to healthy behaviors 
such as following a low-salt and low-fat diet, getting regular exercise, and reducing stress, 
patients with hypertension must also adhere to antihypertensive medications. Poor medication 
adherence may be driven by psychosocial and behavioral factors; however, the impact of these 
factors on medication adherence is unclear especially within the African American community.  
To date, a paucity of research has examined the relationship between psychosocial and 
behavioral factors such as reported racial discrimination, John Henryism (a measure of active 
coping and an unhealthy response to stress) and home remedies with medication nonadherence.  
However, each of these factors has individually been linked with poorer health outcomes among 
African Americans.   
Using data from the TRUST study (2006-2008) the association between these constructs 
and medication adherence was assessed within our sample of 788 African Americans and a 
comparison group of 137 White participants with hypertension. Ordinal logistic regression was 
used to assess the association between racial discrimination, John Henryism, home remedies, and 
medication adherence.   
The findings from this research indicated more reported racial discrimination, higher 
John Henryism scores, and greater use of home remedies were associated with lower medication 
adherence. These findings yield new knowledge about medication adherence and provide 
practical insights about the psychosocial and behavioral determinants of medication adherence.  
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Within the Cooper Green Mercy Healthcare System located in Birmingham, Alabama, 
approximately 80% of the African Americans patients diagnosed with hypertension have 
uncontrolled hypertension.1 Typically African Americans with uncontrolled hypertension are at 
greater risk of experiencing more severe complications and worse health outcomes.2  However, 
the risk of developing these complications can be reduced by engaging in healthy behaviors such 
eating a low-salt diet, regularly engaging in physical activity and adhering to antihypertensive 
medications. Yet, nonadherence to antihypertensive medication continues to average around 
50%.3 
Medication nonadherence is one of the leading prescription-related problems in the 
United States.  Each year nearly 125,000 deaths from cardiovascular disease are attributed to 
medication nonadherence.4,5 Poor adherence may be driven by psychosocial and behavioral 
factors; however, a complete understanding of the association between these factors and 
medication adherence remains elusive.  
Therefore, the overarching goal of this dissertation was to conduct a cross-sectional 
examination into the association of selected psychosocial and behavioral determinants of 
medication adherence among African Americans using existing data (2006-8) from the TRUST 
study. The parent study was approved by the IRB at Cooper Green Mercy Hospital and the IRB 
at the University of Alabama at Birmingham.  The present study was reviewed and approved by 
the IRB at the University of Massachusetts Medical School.   The National Heart Lung and 
Blood Institute funded the TRUST study and the present study was funded by a dissertation grant 
from the Agency for Healthcare Research and Quality.  
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The outcome variable for the three aims of this study were medication adherence, which 
was measured using the Morisky Medication Adherence scale.6  
The objective of the first aim was to determine if more reported racial discrimination was 
associated with lower medication adherence.  We hypothesized that participants reporting more 
discrimination would report lower adherence than individuals reporting fewer experiences of 
discrimination, and patients experiencing more discrimination would be less trusting in the 
healthcare system.  Additionally, individuals reporting low trust would report worse adherence to 
medication. The main independent variable was reported racial discrimination, measured by the 
Krieger Experiences of Discrimination scale.7 Trust, measured by Hall General Trust scale was 
tested as a potential mediator for the association between discrimination and medication 
adherence.8  
The objective of the second aim was to determine if higher John Henryism, a measure of 
active coping was associated with lower medication adherence.  We hypothesized that 
participants reporting higher John Henryism would report lower adherence. The main 
independent variable for the second aim was John Henryism measured using the John Henryism 
Active Coping scale.  Trust, measured by Hall General Trust scale was again tested as a potential 
mediator.8  
The objective of the final aim was to determine if use of home remedies was associated 
with medication adherence and to determine if home remedies were being used as a substitute for 
antihypertensive medications. The main independent variable for this aim was home remedies 
measured using reported home remedy use, types of home remedies used, and number of home 
remedies used.  
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1.1 Hypertension among African Americans    
According to the Center for Disease Control and Prevention, hypertension is the primary 
or contributing cause of death for over 326,000 Americans each year.9  Approximately one in 
three adults in the United States (US) is affected by hypertension; however, there are noted 
disparities in the prevalence, treatment, and control of the disease.   African Americans have a 
higher prevalence of hypertension than their White counterparts.   The National Health and 
Nutrition Examination Survey (NHANES), 1999-2000, estimates the age-adjusted prevalence of 
hypertension among African Americans was 44.1%, compared to 28.1% found among Whites.10 
African Americans are more likely to have undiagnosed hypertension, suggesting that the 
already noted burden of hypertension within this population is underestimated.11  Findings from 
the Dallas Heart Study, a study of the prevalence, treatment and control of hypertension among 
African Americans indicated the prevalence of hypertension was 64.4%.  Of those diagnosed 
50.6% of the study participants were receiving treatment for hypertension and only 26.9% had 
controlled hypertension.12 The asymptomatic nature of hypertension allows patients to live with 
the disease without experiencing complications until it has progressed significantly.  Patients that 
are unaware of their condition typically do not receive care, contributing to an increased risk of 
developing severe complications.    
African Americans are more likely to have uncontrolled blood pressure, which 
contributes to an increased risk of stroke, kidney disease and coronary heart disease (CHD).11  
CHD is a leading cause of health-related disparities.  The American Heart Association estimated 
that approximately 37% of the Black-White life expectancy gap can be attributed to coronary 
heart disease.13  Moreover, statistics indicate that the Southern region of the United States, where 
41% of African Americans in the US reside, has the highest burden of cardiovascular disease.  
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The setting for the present study was Birmingham, Alabama.  The state of Alabama ranked 2nd in 
the United States in number of deaths from cardiovascular disease and ranked 3rd in the United 
States with the highest number of strokes.14  
 
1.2 Medication Adherence in the United States 
Inadequate medication adherence among those with chronic conditions contributes to 
poorer health outcomes and increases healthcare cost.  According to the American Heart 
Association more than half of all patients with chronic disease do not follow their physician 
instructions regarding their prescriptions and two-thirds do not take any or all of their prescribed 
medications.15  Each year nearly 125,000 deaths from cardiovascular disease can be attributed to 
medication nonadherence.4,5,16-18 Hypertension is a condition that requires constant management, 
primarily through the use of antihypertensive medications.  The inability to afford medications 
has been noted as a barrier to medication adherence among African Americans.19-21 This is 
particularly important for those managing multiple chronic conditions and are required to take 
several medications each day; as these patients endure costly out-of-pocket expenses for 
prescriptions.  Recent studies have highlighted several additional factors that contribute to lower 
adherence; such as forgetting to obtain refills, lack of transportation, access to care, limited drug 
coverage, low health literacy, and managing multiple comorbidities.21 
Previous studies indicated statistically significant differences in medication adherence 
rates between African Americans and Whites.22,23 A recent national survey administered by the 
Health Institute at Tufts-New England Medical Center assessed medication adherence among 
14,829 African-American, Hispanic, and White senior citizens.  The results indicated statistically 
significant differences between race/ethnic group and adherence rates.24  Nonadherence rates 
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among African Americans, Hispanics and Whites were 45.3%, 48.8%, and 41.1% respectively, 
while the results were statistically significant, the actual difference in adherence rates between 
African Americans and Whites was less than 5%. These findings indicate little difference 
between the adherence rates by race, and that nonadherence is not only a growing concern for 
minority populations but a general problem for individuals managing chronic conditions. 
 
1.3 Reported Discrimination  
Racial discrimination, as defined by Blank and Dabady, is the differential treatment on 
the basis of race that disadvantages a racial group.25  Racial discrimination is a more common 
experience among underrepresented minorities and those with disadvantaged backgrounds.  A 
growing body of literature has examined the association of reported discrimination with 
healthcare seeking and self-care behaviors.  Additionally, experiencing discrimination has been 
linked with lower healthcare utilization26-28 and has been suggested as a barrier to medication 
adherence.29-31  Haussmann and colleagues found that participants reporting discrimination were 
less likely to use preventive services compared to those reporting no discrimination.27 A study 
conducted at Duke University among African-American and Latino patients found adherence 
among African Americans was worse than among White participants; however, when they 
controlled for discrimination being African American did not account for prescription delays. 
The findings of this study suggest past experiences of discrimination, which produce lower trust 
and lower engagement in the medical system may be the cause of these disparities and not 
simply an issue of race.32  Thus, these findings suggest that reported racial discrimination may be 
linked with medication adherence and that trust may potential mediate the association between 
discrimination and medication adherence.  
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1.4 John Henryism  
John Henryism, a measure of extreme active coping, refers to individuals with an 
efficacious mental and physical vigor, a strong commitment to hard work, and a single-minded 
determination to succeed.  The scale is comprised of questions such as “When things don’t go 
the way I want them to, that just makes me work even harder.” John Henry was the “steel driving 
man” who in the folktale beat the steam machine but lost his life in the process.33 Sherman 
James, the sociologist that developed the John Henryism hypothesis found that lower 
socioeconomic status (SES) African Americans were three times more likely to have 
hypertension than individuals of higher SES.34  The increased risk of hypertension found among 
individuals with a lower SES may result from frustration and feelings of helpless when 
experiencing unfair or discriminatory behavior.   
Stress is a major risk factor for the development and exacerbation of hypertension.33,35 
Additionally, the way one copes with stressful experiences has been linked to blood pressure 
responses.36-38  African Americans and those of lower SES are more frequently exposed to 
environmental stressors.39  The most common methods of coping with stress are 1) passive: 
accepting the experience, not discussing the experience and internalizing it, 2) active: taking 
action or talking about the experience, 3) spiritual: praying, and 4) adverse: eating or drinking 
excessively to cope with stressful experiences.30 Active coping does not necessarily predispose 
one to poorer health outcomes; in fact, it can lead to proper self care.40  However, it has been 
suggested that extreme levels of active coping or hyper-active coping may be related to elevated 
blood pressure and poorer health outcomes.37  To date, John Henryism has not been linked with 
medication adherence.   
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1.5 Use of Home Remedy  
Home remedies are often used as a supplement or alternative to prescriptions and 
traditional treatments.41  Researchers that have explored the use of home remedies have 
identified several factors that contribute to a patient’s decision to use home remedies.  These 
factors include fears of conventional medication, limited access to care, and inability to afford 
conventional medicine.41  Many patients consider home remedies healthier and safer, and regard 
them as an appropriate treatment for managing chronic conditions, such as hypertension.42  
Patients taking antihypertensive medications may report experiencing symptoms such as 
headaches, dizziness, drowsiness, dry mouth, and frequent urination from the use of 
antihypertensive medications.  These patients may instead turn to garlic, lime, spicy foods, 
cinnamon, and oatmeal instead of antihypertensive medications.42 
 Cultural factors also play a role in the use of home remedies; several studies have linked 
the use of home remedies to Latinos and African Americans.42-44  An analysis of 2,107 
participants of the National Survey of Black Americans (NSBA) found 69.6% of study 
participants reported their families used home remedies, and 35.4% reported using home 
remedies themselves.  The authors found religiosity and lower education were associated with 
increased use of home remedies.45 Home remedy use is a growing concern for African 
Americans with hypertension.  The determinants of home remedy use are poorly understood 
among African Americans and how these factors contribute to medication adherence warrant 
further examination. 
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1.6 Conceptual Framework  
Medication nonadherence may be 
associated with a variety of 
psychosocial and behavioral factors 
e.g. discrimination, trust, John 
Henryism and the use of home remedies. The guiding framework for the present study is an 
adapted version of the Model of Disease Self-Management.46  The Model of Disease Self-
Management was developed to conceptualize disease management of older patients with 
chronic diseases such as hypertension.  The model is based on three assumptions: 1) several 
factors predispose one to manage a disease, 2) patient management is the conscious use of 
strategies to manipulate situations to reduce the impact of disease on daily life, and 3) illness 
management is not an end itself but the means to other ends.  The model is illustrated in 
Figure 1.1.  Previous studies have shown that sociocultural (discrimination and coping) and 
behavioral factors (home remedy use) are associated with hypertension disease management 
and medication adherence.31,47 Patient characteristics such as age, gender, SES, and 
functional status (SF-12) may be differentially associated with reported discrimination, 
coping style, and use of home remedies.  Additionally, experiencing discrimination may lead 
to lower trust, coping actively with stress may lead to lower trust.  These psychosocial and 
behavioral factors may lead to poorer medication adherence and may ultimately result in 
poorer health outcomes such as higher blood pressure and uncontrolled hypertension.  
This model was based on findings from existing literature on medication adherence and 
discrimination, coping, and home remedies.  The relationships depicted in Figure 1.1 are  
hypothesizes associations that may suggest the direction of the casual pathway. Because this 
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study is not focused on hypertension control, blood pressure, and health outcomes, these 
constructs were omitted from the model.  However, the model is easily expandable to 
accommodate these more distal health outcomes as this line of work is advanced in future 
studies.  
 
1.7 Summary 
The barriers to medication nonadherence and the interrelationship between nonadherence 
and social and behavioral factors among African Americans with hypertension remain unclear. 
The findings from this study will build on prior studies of the root causes of cardiovascular 
health disparities, and serve as the foundation for future research that will deliver culturally-
tailored interventions for promoting improved health behaviors for African Americans with 
hypertension. It will also open new avenues into the continued research of psychosocial and 
behavioral determinants of medication nonadherence.  The findings from this research will 
provide a foundation to develop a comprehensive conceptual model that illustrates the 
association between these psychosocial and behavioral factors and medication nonadherence.  
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CHAPTER II 
 
 
Reported Racial Discrimination, Trust in Physicians, and 
Medication Adherence among Inner-City African Americans with 
Hypertension 
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2.1 ABSTRACT 
 
Introduction: African Americans have a higher prevalence of hypertension and may face special 
challenges in trying to obtain control of their condition. Medication nonadherence is poorly understood, 
particularly among African Americans. Psychosocial and behavioral factors have been cited as potential 
barriers to medication nonadherence. The objective of this study was to determine if reported racial 
discrimination is a determinant of medication adherence and if trust mediates this association.   
Methods: Data were obtained from the Alabama Collaboration for Cardiovascular Equality, 2006-2008.  
Study participants self-reported medication adherence using the Morisky Adherence scale. We collapsed 
the two lowest categories of medication adherence due to low cell counts.  Discrimination was measured 
using the Krieger Experience of Discrimination Scale. Trust was assessed using the Hall General Trust 
scale. Associations were quantified using ordinal logistic regression, and we adjusted for multiple 
confounders including education, income, and age. 
Results:  Our sample consisted of 229 African American males and 558 African American females, with 
an average age of 53.7 +/- 9.8 years. There was an inverse association between discrimination and 
medication adherence (high adherence: 3.41, moderate adherence: 4.30, and low adherence: 4.75, and p 
for trend: p>0.025).  Results persisted after adjusting for multiple covariates. Mediation analysis revealed 
trust partially explained 39% of the association between discrimination and medication adherence.  
Conclusion:  Within our sample of inner city African Americans with hypertension, more perceived 
racial discrimination was associated with lower medication adherence. Our findings highlight the 
importance of discrimination and trust among African Americans.  Patient, physician and system 
interventions to promote trust may be an effective approach for improving medication adherence.  
 
 
 
 
Keywords: Discrimination; Racism; African Americans; Trust; Distrust; Medication Adherence; 
Compliance 
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2.2 Introduction 
The prevalence of hypertension among African Americans is among the highest in the 
world and steadily increasing.33  Current projections estimate that by 2030 the prevalence of 
hypertension may increase by 9.9%.  Within the United States, the prevalence of hypertension is 
44.4% among African-American women and 41.4% among African-American men, compared to 
28.1% among White women 28.1% and 31.5% among White men.48 Obtaining adequate control 
of high blood pressure proves to be a challenge for African American with hypertension. 
Findings from the NHANES study indicated roughly 33.4% of Whites had controlled 
hypertension compared with 28.1% of African Americans.14 Adherence to antihypertensive 
medication is the most effective method for obtaining control of hypertension. Approximately 
50% of the two billion prescriptions filled each year are taken incorrectly or not taken at all.49 
Yet, the causes of nonadherence are poorly understood and warrant further examination.  
The inability to afford medications accounts for 40% of the nonadherence found in the 
general population.21,50-52 Nonetheless, the existing evidence has shown that when patients are 
provided access to medication at a reduced cost or at no cost at all, some patients continue to be 
nonadherent.53 A study from the National Health and Nutrition Examination Survey indicated 
that adherence to antihypertensive medications was lower among African Americans than other 
racial/ethnic groups; however, the differences could not simply be attributed to demographics, 
socioeconomic status (SES), or health risk behaviors. The authors hypothesized that 
psychological and social factors may contribute to these differences, and factors such as 
language proficiency, cultural beliefs, and attitudes toward healthcare may serve as barriers to 
medication adherence.  
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Social factors such as racial discrimination are gaining interest as potential determinants 
of nonadherence. To date, racial discrimination has been linked with a variety of health outcomes 
including low birth-weight, breast cancer, hypertension, stress/anxiety disorder, and poor health 
status.32,54 Experiencing racial discrimination in the healthcare setting may affect the way a 
person accesses, receives, and utilizes healthcare services.  Additionally, racial discrimination 
has been linked with adverse physiological as well as psychological responses.  Experiencing 
racial discrimination has also been linked with elevated heart rate and cardiovascular reactivity, 
increased risk of hypertension, as well as poor hypertension control.55,56 A study of African-
American college students found that viewing film clips depicting acts of racism toward African 
Americans contributed to elevated blood pressure among the participants.36 In addition to the 
physiologic responses resulting from discrimination, the psychological impact has been shown to 
erode health and health seeking behaviors.  
Racial discrimination has been linked with psychological responses such as lower trust in 
healthcare providers.43,57,58 For example, patients that have experienced discrimination in any 
setting (including healthcare) may seek care with the expectation that they may encounter 
discriminatory behavior.  Thus, these patients are more likely to be distrustful towards healthcare 
providers which may also contribute to these patients avoiding care.58 Additionally, existing 
evidence indicates that patients that have lower trust are less likely to follow healthcare providers 
instructions, less likely to seek out healthcare, and less likely to utilize preventive services as 
described in a study by O’Malley et al.43 The findings from the O’Malley study and similar 
studies suggest that discrimination may be linked to health outcomes and health behaviors such 
as preventive screenings and that trust may mediate this association.  To date, few studies have 
assessed the relationship between reported experiences of discrimination and health behaviors.   
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Therefore, we examined the association between reported experiences of discrimination 
and medication adherence. We first explored racial discrimination and the association with 
medication adherence among African Americans with hypertension.  Second, we assessed the 
mediating effects of patient-provider trust.  
 
2.3 Methods 
 
2.3.1 TRUST Study Data and Sample 
 The TRUST study was a subproject within the Alabama Collaboration for Cardiovascular 
Equality (ACCE) project, 2006-2008.  The objectives of the TRUST study were to examine 
factors such as discrimination, trust, self-efficacy, access to care, and medication adherence 
among African Americans with hypertension living in the inner city.   Study participants were 
recruited from the Cooper Green Mercy Hospital System, a safety-net setting in Birmingham, 
Alabama.  The TRUST study was approved by IRBs at the University of Alabama at 
Birmingham and Cooper Green Mercy Hospital.  The present study was approved by the IRB at 
the University of Massachusetts Medical School. Patient screening was conducted after obtaining 
local IRB approval and informed patient consent. Survey data were collected through in-person 
interviews using computer-assisted protocols with interviewers trained by the University of 
Alabama at Birmingham (UAB) Minority Health Research Center. Medical records were used to 
ascertain cardiovascular disease (CVD) risk factors, diagnoses, and findings related to end-stage 
organ damage associated with CVD, and quality of care. Approximately 5% of medical record 
were dually abstracted with >95% reliability and validity agreement (inter-rater reliability).   
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2.3.2 Inclusion/Exclusion Criteria 
 Eligible participants were defined as patients that self reported race/ethnicity as African 
American, received primary care from Cooper Green Mercy Hospital for a diagnosis of 
hypertension, were 19 years old or older, were able to provide informed consent, and were not 
pregnant (n =788).  Patients were excluded if they did not respond to questions regarding 
medication adherence, discrimination, and/or trust (n=8).   
 
2.3.3 Dependent Variable- Medication Adherence 
 The dependent variable for this study was self-reported medication adherence, measured 
using a modified version of the 4- item Morisky Medication Adherence Scale.6 The Morisky 
Medication Adherence Scale consist of the following questions: 1) “Do you ever forget to take 
your medicine?; 2) Are you careless at times about taking your medications?; 3) When you feel 
better do you sometimes stop taking your medicine?; and 4) Sometimes if you feel worse when 
you take the medicine do you stop taking it?”  The Morisky scale has a dichotomous (yes/no) 
response option. A score for the Morisky scale is calculated based on responses to the four 
questions, with responses of yes or no adding 0 and 1 point respectively. The original Morisky 
scale ranges from 0 to 4, with a lower score indicating worse adherence. For this study, we 
modified the Morisky scale by combining the two lowest adherence categories (0 and 1) and the 
two middle adherence categories (2 and 3).  Collapsing the categories produced a three level 
adherence variable. We modified the Morisky scale due to low cell counts in the lowest 
adherence categories.   
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The validity of the Morisky scale has been confirmed in several studies, including in 
studies with only African-American participants.6,59,60 The Morisky Scale was originally 
validated in a sample of 400 patients with hypertension, of which 91% were African American. 
The Morisky scale has a limited internal consistency and reliability, with a Cronbach’s Alpha of 
0.61.  
 
2.3.4 Primary Independent Variable- Reported Racial Discrimination 
Discrimination was measured using the Krieger Experiences of Discrimination Scale 
(EOD).7 The EOD scale was originally developed within a sample of 51 African Americans and 
50 White women in Alameda County, California.  The EOD is a four-item scale, which collects 
data on race, weight, and gender-based discrimination.  For this study, the question pertaining to 
racial/ethnic discrimination was included.  The EOD scale consists of the following question: 
Have you ever experienced discrimination, were prevented from doing something, hassled or 
made to feel inferior in any of the following six situations because of your race or color?  For the 
present study, we modified the EOD scale to include seven settings for discrimination 1) school 
2) getting a job 3) when getting housing 4) at work 5) at home 6) when seeking medical care and 
7) in public.  Each setting receives a score of 0 to 3 based on the response of never, rarely, 
sometimes, or often (scored respectively). The total experience of discrimination scale ranges 
from 0 to 21 with a higher score indicating more reported discrimination. 
 
2.3.5 Mediator 
Trust was measured using the Hall General Trust scale8 which had an internal 
consistency of 0.89 indicating good reliability.  The Hall Trust scale consists of 25 questions 
related to patient trust in physicians based on five domains: 1) caring about the patient’s best 
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interest; 2) physician competence; 3) honesty; 4) confidentiality; and 5) global trust.   The Hall 
Trust scale ranges from 11 to 54 with a higher score indicating greater trust.   
 
 2.3.6 Secondary Independent Variables 
The following secondary independent variables were assessed in this study.  Measures of 
self-reported socioeconomic status included income, education and difficulty paying for medical 
care.  Income was categorized as:  <$5,000, $5,000-$11,999, $12,000-$15,999, and $>=16,000; 
education was divided into four categories; less than HS, HS, some college, college degree; and 
the variable of difficulty paying for medical care was categorized as not hard, somewhat hard, 
hard, very hard. Demographic variables of gender and age were also included.  
 
2.3.7 Statistical Analysis 
Bivariate comparisons were conducted using ANOVA for continuous variables and the 
chi-square test for categorical variables.  The threshold for statistical significance was set at  p < 
0.05.  The Morisky outcome variable is a three-level ordinal measure; therefore, cumulative 
ordinal logistic regression was used to examine multivariable relationships.61,62 Mediation 
analysis was used to determine the extent to which the relationship between discrimination and 
medication adherence was explained by trust.  Mediation analysis was performed using extended 
techniques from the tradition of Baron and Kenny.63 The mediated effect was taken as the 
difference between the regression coefficient of the main independent variable (discrimination) 
with (c’) and without (c) adjustment for the mediator (general trust).  When applying these 
techniques to dichotomous outcomes, it is best to avoid comparing the regression coefficients 
across equations. Since logistic and ordinal logistic regression model the unobserved, latent log 
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odds probability of the outcome, the variance of the outcome changes as covariates are added or 
removed from the regression equation, thus creating a “scaling” effect.  To account for this 
scaling effect, we standardized the regression coefficients before conducting the mediation 
analysis.  
First, we calculated the change in the standardized coefficient for the main independent 
variable after adjusting for the mediator (c-c’).  Next, we calculated the mediated proportion of 
the ratio, and the change to the original value of the standard coefficient (c-c’)/c.  The mediated 
proportion approximately represents the proportion of the total effect of the independent variable 
that is transmitted through the mediator.64 Confidence intervals were generated for the mediated 
proportion by 1000 replications using bias corrected and accelerated boot strapping.65 Statistical 
analysis was conducted using STATA version 12 (StataCorp, College Station, TX).  
 
2.4 Results 
 
2.4.1 Sociodemographic Characteristics of the Participants 
 Our sample consisted of 780 African Americans recruited from a safety-net hospital in an 
inner city in the Deep South. The study sample consisted largely of women (71%), and had an 
average age of 53 years.  Low adherence was fairly infrequent in our sample as approximately 
112 (14%) participants reported low adherence, 350 (45%) reported moderate adherence, and 
318 (41%) reported high adherence. Our sample was low income with 66% reporting an income 
of less than $11,999; yet, most participants reported attending some college (69%). Within our 
sample, the mean score for reported racial discrimination score was 4.02, and the study sample 
reported a mean trust score of 39.02.   
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2.4.2 Medication Adherence 
The characteristics of the study participants stratified by medication adherence level are 
described in Table 2.1.  Significant differences across adherence level were found in terms of 
level of reported racial discrimination, age, gender, and trust in physicians. Participants in the 
low adherence category reported more discrimination (4.75) than those in the high adherence 
category (3.41) and reported lower trust (36.53) than the high adherence category (40.84).  
Individuals in the low adherence category were typically younger and male participants reported 
better adherence to medication.  No statistically significant differences were found in terms of 
education or income.  
 
2.4.3 Discrimination and Medication Adherence 
 The results of the adjusted analysis are presented in Table 2.2.  Model 1 presents the 
adjusted association between medication adherence and discrimination. Model 2 is the adjusted 
association between medication adherence and discrimination, including trust as a mediator. In 
the first model, each one-point increase in reported discrimination reduced the cumulative odds 
of being in a better medication adherence category by 6% (OR: 0.94 CI: 0.91-0.97).  Greater 
adherence to medication was associated with increased age (OR: 1.02 CI: 1.01-1.04), having a 
college education (OR: 1.86 CI: 1.03-3.34), an income between $12,000-15,999 (OR: 1.62 
CI:1.05-2.48) and being male (OR: 0.64 CI: 0.47-0.87).   
The second model, which included trust as a mediator, indicated that the association 
between racial discrimination and medication adherence persisted even after trust was introduced 
into the model.  As presented in Table 2.2, racial discrimination reduced the cumulative odds of 
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being in a better medication adherence category by 4% (OR: 0.96 CI: 0.93- 1.00).  Trust was also 
significantly associated with medication adherence as greater trust increased the cumulative odds 
of being in better medication adherence category by 4% (OR: 1.04 CI:1.02-1.06).  
Standardized Beta Coefficients were used to calculate the mediated proportion.  In model 
1, the standardized beta coefficient for discrimination was -0.145.  However, when trust was 
included in the model, the standardized beta coefficient associated with adherence and 
discrimination was reduced to -0.089 moving the findings closer to zero indicating the 
association between discrimination and adherence reduced.  As illustrated in Figure 2.1 we 
calculated the mediated proportion, our results indicated that trust mediated 39.01% (95% CI: 
15.4 - 92.5) of the association between discrimination and medication adherence.   
 
2.5 Discussion 
 The findings of the present study highlight the negative effects of reported experiences of 
racial discrimination, and the relationship between racial discrimination and medication 
nonadherence.  Within our cohort of African Americans with hypertension, more reported racial 
discrimination was associated with lower medication adherence. Participants reporting high 
adherence were typically older, male, and reported greater trust. One hypothesis for these finding 
is that female participants in our study may report lower adherence as a result of neglecting to 
manage their own condition and placing priority on the healthcare needs of the rest of the 
family.66 Education was also associated with better medication adherence in this cohort; a 
possible hypothesis for this finding is that most participants attended some college or completed 
college and likely had better health literacy than the other participants which might have 
contributed to better comprehension of physicians instructions.67  
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We found a statistically significant relationship between discrimination and medication 
adherence. These findings support the findings of previous reports. Van Houtven conducted a 
study in Durham County, North Carolina; the participants consisted of 522 Black, White, and 
Latino study participants.32 The results of this study indicated a significant associations between 
reported racial discrimination and patients delaying to fill prescriptions. They further analyzed 
the difference in prescription delays between Black and White participants and found that race 
was not the source of the differences, but it was discrimination itself that contributed to the 
difference. In a meta-analysis that examined the association between racial discrimination and 
health, the findings indicated that reported discrimination was related to lower participation in 
healthy behaviors.68 The authors of this study analyzed 134 samples, and their findings indicated 
that discrimination had negative effects on physical and mental health. In contrast with these 
studies, other studies have failed to find an association between racial discrimination and health 
outcomes. For example, a study conducted by Peters et al assessed the association between 
racism and hypertension among 162 African American adults.69 Approximately 83% of the 
participants reported experiencing unfair treatment.  However, a statistically significant 
association between racism and blood pressure was not detected.  The authors noted that their 
findings might be due to the fact the majority of their study participants, including those that 
were previously diagnosed with hypertension, were normotensive.  
 Lastly, mediation analysis indicated trust explained 39% of the association between 
discrimination and medication adherence. Several studies have addressed the importance of a 
trusting relationship between the provider and the patient. Kressin et al conducted a study 
examining factors related to blood pressure control, sociodemographics, and personal beliefs 
about blood pressure and blood pressure medication.70 African-American participants reported 
  
38 
 
more experiences of discrimination than White participants, and the authors suggested that these 
experiences might have eroded overall trust in physicians.  Historical mistreatment of African 
Americans seeking care has contributed to the mistrust seen among African-Americans care-
seeking behavior.71 Boulware et al, found that African-American participants were less likely to 
report trust in their physicians when compared to white participants.72 They attributed the lower 
trust found among African Americans to underlying fears of experiencing race-based 
discrimination. Similar to our findings which suggest that lower trust contributes to poorer 
adherence, Piette et al found that patients with lower trust in physicians were more likely to 
underuse medications in response to medication adherence cost pressures.73 The participants in 
the Piette study were similar to those in our study as the majority of the study participants in both 
studies reported an income of less than 25,000.  
 
2.5.1 Strengths and Limitations 
 Our study presents a novel approach to exploring barriers to medication adherence, and 
while there are several strengths to this study, there are also limitations that we must address.  
Due to the cross-sectional design of our study, we are limited in our ability to confirm causal 
associations.  Additionally, our study sample was recruited in Birmingham, Alabama and thus 
our results may not be generalizable to African Americans in other regions of the United States. 
The parent study did not incorporate objective measures of medication adherence, such as pill 
count due to the prohibitive cost. However, it is important to note that no single method has been 
identified as the gold standard for collecting data on medication adherence.74 The focus of this 
study was specifically to assess medication adherence as an outcome; we did not examine blood 
pressure levels or other clinical outcomes.  Our results used self-reported medication adherence, 
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which may potentially contribute to over or under-reporting.75   It is also possible that our 
patients did not fully disclose or recall their nonadherence to medications, contributing to recall 
bias. Some of the strengths of our study include our relatively large sample of inner-city African 
Americans, and the survey instruments we used to collect study data have all been validated in 
African Americans. Finally, this is one of the first studies to examine trust as a mediator of 
discrimination and medication adherence. 
 
2.5.2 Implications 
 Promoting adherence to medication remains a formidable task for researchers and 
healthcare providers. Based on our findings we provide simple suggestions and next steps for 
researchers interested in promoting medication adherence among African Americans. First, 
offering training that emphasizes racial sensitivity, facilitates patient-physician trust, and 
addresses implicit bias76  and promotes cultural competency might improve communication 
between patients and providers.   Researchers interested in developing scales for measuring 
barriers to medication adherence might also consider incorporating measures of trust when 
collecting study data.  Questions that address mistrust will provide a more comprehensive vision 
of the barriers to medication adherence.  
 Another promising approach for enhancing medication adherence among African-
American patients is through narrative based interventions (or storytelling).  Storytelling is a tool 
used for preserving oral history and sharing encouraging and inspirational messages, as well as a 
method for communicating information.77 Narrative-based interventions have been proven to be 
an effective method for promoting positive health behaviors. The Culturally Sensitive 
Intervention (CSI): Birmingham is a recent study that used storytelling as a tool to promote 
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better health behaviors among African Americans with hypertension.  In the CSI study the 
participants shared their stories of mistrust and apprehension about speaking with physicians 
about their condition.  The patients also shared motivational tips and techniques for overcoming 
feelings of mistrust towards healthcare providers. Storytelling interventions among American 
Indians have shown great potential as a technique for promoting better patient-provider 
communication; breaking down issues of mistrust, helping patients cope with perceived 
discrimination, and sharing tips and techniques for improving medication adherence.78 
Successful storytelling interventions have highlighted the importance of having patient share 
their experiences through storytelling with similar patients.  Through storytelling, patients can 
discover ways of overcoming communication barriers with physicians, and techniques for coping 
with mistreatment if they should experience it when seeking healthcare.  
 
2.5.3 Conclusions 
Our findings contribute to the growing empirical evidence pointing to an association 
between racial discrimination and health behaviors. Greater reported discrimination was directly 
linked with lower adherence in our sample of African Americans.  We also found that low trust 
was not only linked with more reported discrimination but also linked with poorer adherence to 
medication. It is our hope that our findings from this research provide greater clarity to the role 
of discrimination and trust in healthcare.  Additionally, we hope these findings will be used and 
incorporated into future medication adherence interventions, and that by better understanding the 
factors that contribute to poorer medication adherence we will see marked changes in 
cardiovascular health disparities.  
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Table 2.1 Characteristics of 780 African American Participants with Hypertension in the TRUST Study by 
Adherence Levels, 2007-2008 
 Adherence Levels**  
 Low= 112 Moderate n=350 High=318 p-value 
Discrimination, meana 4.75 4.30 3.41 0.025 
Age, mean 50.78 53.58 54.83 <0.001 
Females, %    0.018 
Male 8.81 48.02 43.17  
Female 16.64 43.58 39.78  
Education, %     0.315 
Less than HS            14.07 46.67 39.26  
High School 21.05 42.11 36.84   
Some College 13.82 44.74 41.45   
College Degree 8.00 46.67 45.33   
Income, %     0.281  
less than $5,000 16.89 48.86 34.25  
$5,0000-$11,999 14.67 43.63 41.70   
$12,000-$15,999 11.20 41.60 47.20   
>$16,000 11.57 47.93 40.50   
Trust, mean b 36.53 38.53 40.84 <0.001  
*p-values were obtained from two-tailed ANOVA for continuous variables and chi-square for categorical variables.  
aKrieger Experiences of Discrimination Scale which ranges from 0-21  b Hall General Trust Scale which ranges from 11-
54.  Higher scores on the Krieger and Hall scales indicated more reported discrimination and greater trust.  
**The Morisky scale ranges from 0-4, we modified the scale by combining the two lowest and two middle categories to 
produce a three-level medication adherence variable (low, moderate, high).   
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Table 2.2 - Ordinal Logistic Regression Model for the Association between Reported Discrimination and Medication Adherence among 
the 724 African American Participants of the TRUST Study, 2007-2008 
 Model 1 Model 2 
Cumulative 
Odds Ratio 
95% CI Standardized 
Β Coefficient 
Cumulative 
Odds Ratio 
95% CI Standardized 
Β Coefficient 
Discriminationa 0.94 0.91 – 0.97 -0.145 0.96 0.93 – 1.00 -0.089 
Trustb --- --- --- 1.04 1.02 – 1.06 0.175 
Age 1.02 1.01 – 1.04 0.118 1.02 1.01 – 1.03 0.104 
Gender (ref: male) 0.64 0.47 – 0.87 -0.109 0.72 0.52 – 0.99 -0.080 
Education (ref: less than HS)       
HS 0.79 0.48 – 1.31 -0.043 0.74 0.45 – 1.23 -0.056 
Some College 1.26 0.85 – 1.86 0.060 1.26 0.86 – 1.87 0.061 
College 1.86 1.03 – 3.34 0.098 2.01 1.12 – 3.63 0.110 
Income (ref: less than $5,000)       
$5,000-$11,999 1.31 0.93 – 1.86 0.070 1.31 0.92 - 1.85 0.067 
$12,000-$15,999 1.62 1.05 – 2.48 0.097 1.61 1.05 – 2.48 0.095 
>=$16,000 1.23 0.80 – 1.90 0.042 1.20 0.78 – 1.85 0.036 
aKrieger Experiences of Discrimination Scale which ranges from 0-21  b Hall General Trust Scale which ranges from 11-54.  
Higher scores on the Krieger and Hall scales indicated more reported discrimination and greater trust. Discrimination data from 
the Krieger Experiences of Discrimination Scale and Trust data from the Hall General Trust Scale.  
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Figure 2.1 Mediation Model Depicting the Association between Discrimination and Medication 
Adherence with Trust as a Mediator.   
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Chapter III 
 
“Would John Henry take Antihypertensive Medications?” Using the 
Concept of John Henryism to Assess Medication Adherence among 
African Americans. 
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3.1 Abstract 
Objectives:  Each year nearly 125,000 deaths from cardiovascular disease are attributed to medication 
nonadherence.  African Americans typically have higher rates of uncontrolled hypertension contributing 
to higher rates of stroke and coronary heart disease.  Active coping is a psychological mechanism used for 
managing experiences of stress.  The concept of John Henryism refers to the determination to overcome 
all odds and adversities even at the expense of one’s own health. John Henryism has been linked with 
hypertension and negative health outcomes, but rarely with health behaviors. We examined the 
association between John Henryism and medication adherence among African Americans with 
hypertension. 
Methods:  Data were obtained from the Alabama Collaboration for Cardiovascular Equality, 2006-2008.  
Study participants self-reported medication adherence using the Morisky Adherence Scale. John 
Henryism was self-reported by study participants using the John Henryism Active Coping scale.  The 
John Henryism Active Coping Scale is a 12-item scale that ranges from 12 to 60, with a higher score 
indicating higher levels of active coping.  Multivariate associations were quantified using ordinal logistic 
regression.  
Results:  Our sample consisted of 229 African American males and 558 African American females, and 
had an average age of 53.7 +/- 9.8 years. The results revealed participants reporting lower John Henryism 
reported greater adherence to medications (low adherence to high adherence: 20.62, 19.19, 18.12; overall 
p <0.001). Results persisted after the model was adjusted for education, income, discrimination, general 
health status and age.  
Conclusion:  Within this cohort of low-income African Americans with hypertension, John Henryism 
was associated lower adherence to medication.  This study contributes to the growing research examining 
individual barriers to medication adherence and provides greater insights to the factors that contribute to 
higher John Henryism scores. 
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3.2 Introduction 
Seventy-six million people in the United States have hypertension, approximately every 1 
in 3 adults.79,80 The prevalence of hypertension among African Americans is estimated to be 
around 41.4%, and among those that have been diagnosed only 46.1% have obtained control of 
their hypertension.10  African Americans with uncontrolled or untreated hypertension are at the 
greatest risk of developing complications such as stroke and kidney disease.81 The risk of 
developing these complications is greatly reduced with the appropriate use of antihypertensive 
medications.  Nonadherence to antihypertensive medications is estimated to be around 50% for 
patients with chronic diseases such as hypertension.3  Income and inability to afford medications 
are common barriers to medication adherence among underserved and vulnerable populations. A 
recent study by the National Health and Nutrition Examination Survey indicated differences in 
antihypertensive medication use across racial and ethnic groups; yet, they could not attribute 
these differences to simply demographic and socioeconomic factors.53  The authors hypothesized 
these differences may be in part due to social and behavioral factors.   
To date, relatively few studies have examined the association between John Henryism 
and health-related behaviors such as medication adherence. The John Henryism scale is a 
measure of active coping and refers to the willingness to struggle against all odds even in the 
midst of extreme adversity. It is from the legend of John Henry that the concept of John 
Henryism was derived. The legend of John Henry was born from the folktale of an African-
American railroad worker, a steel driver that worked along the Chesapeake and Ohio 
Railway.33,82 John Henry was well known for his great physical strength and his ability to work 
longer and harder than the other railroad workers. While working at the mouth of the Big Bend 
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Tunnel, a salesman selling a mechanical steam-powered drill invites John to participate in a 
competition against the mechanical drill.  The salesman guarantees the drill can out-drill any 
man in the camp, including the renowned John Henry.  In the closing moments of the race John 
Henry beats the steam-powered drill and immediately falls to the ground and dies from complete 
physical and mental exhaustion. This folktale serves as the inspiration for the concept of John 
Henryism and the John Henryism hypothesis.  
Sociologist Sherman James conceptualized the John Henryism hypothesis after years of 
conducting research in the coastal plains region of North Carolina.83  Dr. James noted the 
extraordinarily high rates of heart disease and stroke among the low-income African Americans 
in this region that had gone without adequate explanation. From Dr. James’ experiences with the 
African American community in North Carolina, he fashioned the John Henryism hypothesis, 
which assumes that African Americans with low socioeconomic status (SES) are continuously 
exposed to psychosocial stressors, such as discrimination.48  Like John Henry, individuals 
reporting higher John Henryism are driven to overcome all odds in the presence of difficult 
circumstances and to work to the point of complete physical and mental exhaustion.  John 
Henryism, is a measure of active coping, however it is the extreme levels of John Henryism that 
may be related to negative effects on health.  The risk of hypertension is greater among African 
Americans with limited resources, and this lack of resources increases the vulnerability to 
stress.84  Additionally, the high-levels of mental and physical effort put forth to cope with 
stressful experiences in low-resource and low-income settings contributes to the high prevalence 
of hypertension found among lower income African Americans in the Coastal Plains region of 
North Carolina.85  The existing literature has linked the hypothesis of John Henryism with a 
variety of health outcomes including elevated blood pressure, hypertension, depression, and 
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physical health.33,35-37,86,87 While John Henryism has been linked with health outcomes, rarely 
has the relationship between John Henryism and psychosocial factors such as trust been assessed.   
Patients reporting greater trust in physicians and the healthcare system utilize of health 
care services more frequently, are more complaint with physician recommendations, and have 
better adherence to treatments.58,88 To our knowledge trust has not been linked with the concept 
of John Henryism or any measures of active coping. For example, an individual reporting higher 
John Henryism that believes he or she has been mistreated when seeking healthcare may turn to 
self-care and even home remedy instead of seeking care from a healthcare provider or within the 
healthcare system. These individuals may be less likely to trust the abilities of another individual 
to provide them with quality care and may question their competency. We suspect that this 
relationship between trust in physicians and the healthcare system may serve as a mechanism 
through which the concept of John Henryism translates into health behaviors such as medication 
adherence.  
Therefore, we examined the correlates of John Henryism and medication adherence 
within our cohort of low-income African Americans receiving care in a safety-net setting.  We 
assessed the role of general trust as a mediator of John Henryism and medication adherence.  
Finally, we explored the relationship between John Henryism and medication adherence. 
 
3.3 Methods 
 
3.3.1 TRUST Study 
Data were obtained from the TRUST study 2006-2008; funded by the National Heart, 
Lung, and Blood Institute. Study participants were recruited from Cooper Green Mercy Hospital, 
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a safety-net hospital in Birmingham, Alabama.  The study sample consisted of 788 African 
American men and women with hypertension.  The TRUST study collected data such as reported 
discrimination, trust in physicians, self-efficacy, and medication adherence among African 
Americans with hypertension. The TRUST study received IRB approval from the University of 
Alabama at Birmingham and Cooper Green Mercy Hospital. All patients provided informed 
consent prior to participating in the study.  The present study was approved by the IRB at the 
University of Massachusetts Medical School.   
Survey data were collected through patient interviews and medical charts abstraction.  
Interviews were conducted by three trained interviewers from the University of Alabama at 
Birmingham Minority Health Research Center using Computer Assisted Telephone Interviewing 
(CATI) software. Medical records were abstracted to ascertain data on cardiovascular disease 
(CVD) risk factors, diagnoses and findings related to end stage organ damage, and quality of 
care related to CVD. Approximately 5% of medical records were dually abstracted with >95% 
reliability and validity agreement (inter-rater reliability).  
 
3.3.2 Inclusion and Exclusion Criteria 
Study participants were included if they self-identified as African American, had 
hypertension based physician diagnosis, and were 19 years old or older.  Individuals were 
excluded if they had a mental condition that limited their ability to provide informed consent or 
if they were pregnant.   
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3.3.3 Dependent Variable- Medication Adherence 
  Medication adherence was measured using patients’ self-reported responses to the 4-item 
Morisky Medication Adherence Scale.  The Morisky Medication Adherence Scale consists of the 
following questions: 1) Do you ever forget to take your medicine?; 2) Are you careless at times 
about taking your medications?; 3) When you feel better do you sometimes stop taking your 
medicine?; and 4) Sometimes if you feel worse when you take the medicine do you stop taking 
it? The Morisky Medication Adherence scale has yes or no response options for each of the four 
questions; each yes or no response provides a score of 0 and 1 respectively.  The scale ranges 
from 0 to 4 and a lower score indicates less adherence to medication. Due to low cell counts in 
the lowest adherence categories, we rescaled the Morisky Medication Adherence scale to create a 
three level medication adherence variable by combining the two lowest adherence categories (0 
and 1) and the two middle adherence categories (2 and 3).  The scale was originally validated in 
a sample of 400 patients with hypertension, of which 91% were African American.6 The Morisky 
scale has limited internal consistency (Cronbach’s Alpha of 0.61).6  However, this scale has been 
used to predict poorer health outcomes and was validated in patients with chronic and long-term 
infectious diseases.89,90   
 
3.3.4 Primary Independent Variable- John Henryism  
  John Henryism was measured using the 12-item John Henryism Active Coping Scale.83 
The John Henryism scale is based on three themes 1) efficacious mental and physical vigor, 2) a 
strong commitment to hard work, and 3) a single-minded determination to succeed.  The John 
Henryism scale consists of 12 question including: “1) I’ve always felt that I could make of my 
life pretty much what I wanted to make of it; 2) Once I make up my mind to do something, I stay 
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with it until the job is completely done; 3) When things don’t go the way I want them to, that just 
makes me work even harder; 4) I like doing things that other people thought could not be done; 
and 5) I feel that I am the kind of man/woman who stands up for what he/she believes in 
regardless of the consequences.”  The response options were based on a 5-point Likert scale, 
with possible responses ranging from “completely true” to “completely false”.  A response of 
“completely true” scores 5 points while a response of “completely false” scores 1 point.  The 
scale ranges from 12 to 60, with a higher score indicating higher John Henryism. The John 
Henryism active coping scale has been validated in similar studies that include African American 
participants.91  
 
3.3.5 Mediator 
Trust was measured using the Hall General Trust scale.8  The Hall Trust scale consists of 
25 questions related to patient trust in physicians based on five domains: 1) caring about the 
patient’s best interest; 2) physician competence; 3) honesty; 4) confidentiality; and 5) global 
trust.   The Hall Trust scale ranges from 11 to 54 with a higher score indicating greater trust.  The 
scale has an internal consistency of 0.89, indicating good internal validity.8 
 
3.3.6 Secondary Independent Variables 
 The secondary independent variables for this study included self-reported demographic 
information such as age, gender, annual household income, marital status, level of education, 
mental and physical health status and patient-provider trust.8 Mental and physical status were 
measured using the 12-item Short Form Survey.  The SF-12 scales range from 0 to 100 with a 
higher score indicating better mental or physical health status, the national mean is a score of 50. 
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Annual household income was categorized as <$12,000, and >=$12,000; and education was 
divided into four categories; less than HS, HS, some college, college degree. 
 
3.3.7 Conceptual Model 
The conceptual model below, an adapted version of the model proposed by Clark et al 
illustrates the association between environmental stressors and psychosocial and behavioral 
factors.39 Stress is included in the model as it is central to explaining the mechanism through 
which John Henryism may work. Perceptions of stressful events are influenced by 
socioeconomic factors, cultural factors, and demographic factors. Perception of stressful events 
may depend on the level of resources available to the individual. Socioeconomic, cultural and 
demographic factors may lead to John Henryism as well as trust.  We hypothesized that John 
Henryism and trust are interrelated. Stressful events may lead to a heightened physiological and 
psychological stress response and John Henryism and trust may contribute to that heighted 
response. Past studies have indicated that active methods of coping such as John Henryism are 
linked with greater cardiovascular reactivity.92,93  As such, higher reported John Henryism might 
lead to heightened psychological and physiological responses including constant activation of the 
sympathetic and autonomic nervous systems, and lower trust.94 A heightened psychological 
response may lead to maladaptive behaviors, such as underutilizing the healthcare system or 
being nonadherent to physician’s recommendations.  Also, a heightened physiological response 
such as elevated blood pressure may increase the risk of poorer health outcomes such as 
increased risk of developing cardiovascular disease.  
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Figure 3.1 Conceptual Model of John Henryism- Adapted Version of the Clark et al. Contextual 
Model to Examine the Biopsychosocial Effects of Perceived Racism 
 
 
  
55 
 
3.3.8 Analysis Plan 
 We used descriptive statistics to analyze the frequency, means, and standard deviations of 
all variables.  Next, we examined the associations among SES, psychosocial factors, reported 
discrimination, and trust with John Henryism, John Henryism was used as a categorical variable.  
The process for stratifying participants into categories of low and high John Henryism was 
described by Sherman James. 83  Individuals that scored at or below the sample median were 
classified as low John Henryism (≤19), and those scoring above were classified as high John 
Henryism (>20). Finally, we assessed the association between John Henryism and medication 
adherence; John Henryism was used as a continuous variable.  Multivariable associations were 
quantified using ordinal logistic regression.  The Brant test was used to determine that the 
Proportional Odds Assumption was not violated, which is indicated by obtaining a non-
significant p-value.  
Mediation analysis was used to determine the extent to which the relationship between 
John Henryism and medication adherence was influenced by trust.  Mediation analysis was 
performed using extended techniques from the tradition of Baron and Kenny and Karlson, 
Holmes and Breen.63 The mediated effect was taken as the difference between the regression 
coefficient of the main independent variable (John Henryism) with (c’) and without (c) 
adjustment for the mediator (trust).95  When applying these techniques to dichotomous outcomes 
it is best to avoid comparing the regression coefficients across equations. In logistic and ordinal 
logistic regression models the unobserved latent probability of the outcome, and the variance 
changes as covariates are added or removed from the regression equation, thus creating a 
“scaling” effect.  To account for this scaling effect, we standardized the regression coefficients 
before conducting the mediation analysis.96  
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First, we calculated the change in the standardized coefficient for the main independent 
variable after adjusting for the mediator (c-c’).  Next, we calculated the mediated proportion of 
the ratio, and the change to the original value of the standard coefficient (c-c’)/c .  The mediated 
proportion approximately represents the proportion of the total effect of the independent variable 
that is transmitted through the mediator. 64 Confidence intervals were generated for the mediated 
proportion by 1000 replications using bias corrected and accelerated boot strapping.65 Statistical 
analysis was conducted using STATA version 12 (StataCorp, College Station, TX).  
 
3.4 Results 
The study sample consisted of 787 African Americans with an average age of 53.6 years. 
Seventy-one percent were female, 68.2% had more than a high school education, and 65.9% had 
an annual household income of less than $12,000.   
 
3.4.1 Bivariate Associations of John Henryism and Medication Adherence 
 The findings of the analysis exploring the correlates of John Henryism are presented in 
Table 3.1. Individuals in the high John Henryism category individuals were more likely to report 
low adherence (18.08%) compared to those in the low John Henryism category (11.44%). 
Additionally, individuals in the high John Henryism category reported lower trust in physicians 
(Low: 40.15 High: 37.86; p=<0.001), lower physical health (Low: 37.59 High: 35.86 p=0.002) 
and mental health status (Low: 47.04 High: 43.50; p= <0.001). We did not detect statistically 
significant differences between John Henryism categories by age, gender, education, or income. 
 In Table 3.2 we examined the correlates of medication adherence.  This analysis was 
stratified by adherence level.  Similar to the data presented in Table 3.1, we found an inverse 
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relationship between John Henryism and medication adherence.  Higher John Henryism was 
associated with lower medication adherence (low to high adherence: 20.62, 19.19, 18.12; p-
value=<0.001). Medication adherence was also associated with lower physical (low to high: 
35.28, 36.26, 37.98; p=0.036) and mental health status (low to high: 39.20, 44.98, 48.25; 
p=<0.001), lower age (low to high: 50.78, 53.57, 54.82; p= <0.001), and lower trust (36.52, 
38.53, 40.84; <0.001). We did not detect statistically significant relationships between 
medication adherence and marital status, education and income. 
 
3.4.2 Multivariable Association of John Henryism and Medication Adherence 
 The results of the multivariable analyses are presented in Table 3.3. John Henryism 
remained significantly associated with medication adherence, even after adjusting for multiple 
covariates. Each 1-point increase in the John Henryism scale decreased the odds of being in a 
better medication adherence category by a factor of 4% (OR: 0.96, p=0.014, 95% CI: 0.93 -0.99) 
and trust increased the odds of being in a better medication adherence category by a factor of 4% 
(OR: 1.04, p=<0.001, 95% CI 1.02 – 1.06).  We also found significant associations between 
higher medication adherence and better mental health status, being older, having a college 
degree, and being divorced or separated. Physical health status, gender, and income were not 
significantly associated with medication adherence. The Brant test indicated that the Proportional 
Odds Assumption was not violated (p=0.539).   
 
 
3.4.3 Mediation Analysis  
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Standardized Beta Coefficients were used to calculate the mediated proportion.  The 
mediation triangle tests two potential pathways between the association between John Henryism 
and medication adherence.  The direct pathway, in which John Henryism leads to medication 
adherence, and the indirect pathway in which trust mediates the association between John 
Henryism and medication adherence.  As illustrated in Figure 3.2, the standardized beta 
coefficient for the direct pathway was -0.125.  However, when trust was included in the model 
(the indirect pathway), the standardized beta coefficient for John Henryism was reduced to -
0.094, producing a mediated proportion of 24.34% (95% CI: 10.00 – 66.70).  
 
3.5 Discussion 
Within our cohort of African Americans treated for hypertension in an inner-city safety-
net setting, we examined factors associated with John Henryism and medication adherence.  
Participants reporting high John Henryism reported lower adherence to medication, reported 
lower trust, and had worse physical and mental health status. However, in the adjusted model, 
the associations between medication adherence and physical health status became non-significant 
and new statistically significant associations emerged between college and marital status. Trust 
was also significantly associated with better medication adherence, as the odds of being in a 
better medication adherence category increased by 4%. We assessed the mediating effects of 
trust and found 24% of the association between John Henryism and medication adherence was 
explained by trust. To our knowledge this is the first study to examine the relationship between 
John Henryism and trust.  
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To date John Henryism has not been linked with medication adherence.  However, John 
Henryism has shown associations with several of the secondary independent variables included 
in the adjusted analysis for this study.   
Physical and mental health status had a significant relationship with both John Henryism 
and medication adherence. A recent study by Angner et al. assessed the relationship between 
happiness, a measure of mental health status, and John Henryism.  The researchers found an 
inverse relationship between John Henryism and happiness. The findings from this study were 
obtained from the TRUST dataset, the same data used for the present study. Married participants 
in this study reported better adherence, which is similar to the findings of Kulkami et al and 
Trevedi et al.  In the Kulkami, study married individuals reported better hypertension control. 
Similarly the Trivedi et al study indicated being married contributed to better medication 
adherence.97  
While the majority of studies examining John Henryism, health outcomes, and health 
behaviors have found that the John Henryism hypothesis is supported in the presence of low-SES 
and low resources, these studies suggest John Henryism has negative effects on health.  
However, two studies have found positive effects of John Henryism on individuals with a higher 
income and greater resources.  Bonham et al conducted a cross-sectional examination of the 
association of John Henryism and physical health status, measured using the SF-12.  Within their 
cohort of 339 African American men, respondents with higher John Henryism reported better 
physical health status.98 A study by Light et al examining John Henryism and blood pressure 
among 143 healthy adults found black women and men that were well-educated and employed in 
a high status job reported higher BP levels reported high John Henryism, particularly individuals 
that reported hard work and personal control were the keys to success. Among higher SES 
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income individuals John Henryism may be an adaptive strategy, and may lead to frustration and 
disappointment due limited resources to change life circumstances and chronic physiological 
arousal.33,83,99,100  For example, African American men with a higher-SES may have greater 
access to resources that may also contribute to their better health outcomes. John Henryism may 
serve as a proxy for better self-efficacy or a proactive approach to managing health.  Thus, these 
individuals might view managing their health as a challenge or be more likely to be actively 
involved in the management of their health.  
John Henryism has been linked with positive health outcomes and behaviors among 
Whites of higher socioeconomic status.101-105 Van Loon et al. examined the association between 
John Henryism and health behaviors among 2514 Dutch men and women. 106  The results 
indicated that higher John Henryism was associated with greater reports of smoking cessation. 
The authors hypothesized that the individuals that were able to stop smoking used personal 
characteristics associated with John Henryism to overcome the challenge of smoking.  The Dutch 
population in this study perhaps had a higher income and education and greater access to 
resources. We hypothesize that resources may serve as a proxy for obtaining control over health 
outcomes; additionally resources may enhance the role of active coping efforts in producing 
successful health outcomes.107  
 
3.5.1 Strengths and Limitations 
 There are several strengths to our study; first the study sample consists of a large sample 
of African Americans recruited from an inner-city safety net hospital set in the Deep South. 
Additionally, the present study contributes to the existing evidence of the association between 
John Henryism and health behaviors. In addition to the noted strengths of our study, we must 
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also acknowledge the limitations of our study.  Our study is cross-section; thus; we are unable to 
determine causality.  Next, mediation analysis depends upon the assumption of causality; 
therefore, we rely upon the conceptual model and the published works to support our assumption 
of causality. Our study participants reported relatively low John Henryism scores compared with 
findings in other studies.  However, it is possible that individuals reporting the highest levels of 
John Henryism may do so in an effort to provide a social desirable answer, as the John Henryism 
scale taps into issues of hard work, endurance, and striving for success.48  Our primary objective 
was to assess factors associated with medication adherence, we did not include objective 
measures of blood pressure in this study. Lastly, we used self-reported measures for collecting 
data on medication adherence and John Henryism. While there is no gold standard for measuring 
medication adherence, and objective methods may be more accurate than subjective measures, 
objective measures are more expensive and were not feasible for this study.108   
 
3.5.2 Implications 
John Henryism research holds great potential as a determinant of health behaviors and 
health outcomes.  While the research on John Henryism is growing there are still areas in need of 
exploration.   First, assessing John Henryism through longitudinal studies will clarify the cause 
and effect relationship between John Henryism, health behaviors, and health outcomes. 
Particularly conducting studies that follow young adults as they enter the workforce, and are 
exposed to discrimination and negative experiences. Second, the majority of the studies of John 
Henryism have consisted of African Americans and White individuals, and there is a need to 
expand this research to other minority groups that are vulnerable due to low income, low 
education, and exposed to chronic stressors. Finally, examining the relationship between coping 
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and environment and the relationship between environment and the availability of resources may 
provide greater insights to the factors that contribute to higher John Henryism. 
 
3.5.3 Conclusion 
The findings of this study support the existing evidence that links John Henryism to other 
psychosocial constructs such patient-physician trust, and expands on the existing evidence by 
examining the relationship between John Henryism and medication adherence. It is the 
combination of John Henryism and socioeconomic status in which adverse effects of John 
Henryism are expressed, and that may lead to maladaptive behaviors. The relationship between 
John Henryism and health behaviors is poorly understood and there is an increased need of 
intervention paired with clinical attention for patients reporting high John Henryism. John 
Henryism may be used to identify individuals that are nonadherent, as these individuals have 
been shown to be less trusting and may rely more on self-care and not the healthcare system. 
Additionally, longitudinal studies of John Henryism are needed to clarify the cause and effect 
relationship between John Henryism, health behaviors, and health outcomes.   
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Table 3.1- Bivariate Associations of John Henryism among the 787 African Americans from the 
TRUST Cohort, 2007-2008 
 *Low JH *High JH p-value 
Medication Adherence, (%)a   0.006 
Low Adherence 11.44 18.08  
Moderate Adherence 43.71 46.36  
High Adherence 44.85 35.57  
Trust, meanb 40.15 37.86 <0.001 
Physical Health Status, meanc 37.59 35.86 0.022 
Mental Health Status, meanc 47.04 43.50 <0.001 
Age, mean 54.12 53.09 0.145 
Marital Status, (%)   0.131 
Married 21.90 19.06  
Widowed 17.16 13.20  
Divorced or Separated 38.37 39.00  
Never Married or Cohabitating 22.57 28.74  
Gender, (%)   0.350 
Male 27.77 30.81  
Female 72.23 69.19  
Education, (%)   0.968 
 
Less than HS 17.61 16.86  
HS 14.67 14.24  
Some College 58.47 58.72  
College Degree 9.26 10.17  
Income less than $12,000, (%)   0.370 
Yes 35.47 32.31  
No 64.53 67.69  
The TRUST Cohort  consists of 787 African Americans receiving care in an inner-city, safety-net setting 
that were diagnosed with hypertension. 
*The John Henryism Scale ranges from 0-21. John Henryism categories were obtained using the sample 
median, scores of 19 or greater were defined as high John Henryism, and any scores below 19 were low 
John Henryism. 
aMedication adherence was defined by an adapted Morisky Adherence Scale. bThe Hall General TRUST 
scale ranges from 11-54. 
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Table 3.2 Bivariate Associations of Medication Adherence among the 787 African Americans from the TRUST Cohort, 
2007-2008 
 Adherence Level 
 Low n=112 Moderate n=350 High= 318 p-value 
John Henryism, meana 20.62 19.19 18.12 <0.001 
Trust, meanb 36.52 38.53 40.84 <0.001 
Age, mean 50.78 53.57 54.82 <0.001 
Physical Health Status, meanc 35.28 36.26 37.98 0.036 
Mental Health Status, meanc 39.20 44.98 48.25 <0.001 
Gender, (%)    0.018 
Male 17.86 31.14 30.82  
Female 82.14 68.86 69.18  
Marital status, (%)    0.021 
Married 11.61 19.54 24.92  
Widowed 15.18 13.79 17.67  
Divorced or Separate 45.54 41.95 32.49  
Never Married or Living Together 27.68 24.71 24.92  
Education, (%)    0.315 
Less than HS 16.96 18.00 16.67  
HS 21.43 13.71 13.21  
Some College 56.25 58.29 59.43  
College Degree 5.36 10.00 10.69  
Income Less than $12,000, (%)    0.178 
Yes 27.18 33.33 37.11  
No 72.82 66.67 62.89  
Medication adherence was defined using a modified version of the Morisky Adherence Scale.  The two lowest adherence 
categories and two middle adherence categories were collapsed to form a three-category adherence variable. 
aJohn Henryism obtained from the John Henryism Active Coping Scale, which ranges from12-60 with a higher score indication 
higher John Henryism.  bHall General Trust Scale, which ranges from 11-55 with a higher score indicating greater trust.  
cPhysical and Mental heatlh status obtained from the SF-12 scale, which ranges from 0-100 with a higher score indicating better 
health status.  
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Table 3.3- Adjusted Associations of Better Medication Adherence among 724 African Americans 
from the TRUST Cohort, 2007-2008 
 Adjusted OR 95% CI p-value 
John Henryisma 0.96 0.93 - 0.99 0.014 
Trustb 1.04 1.02 - 1.06 <0.001 
Physical Health Statusc 1.01 0.99 – 1.02 0.321 
Mental Health Statusc 1.03 1.01 – 1.04 <0.001 
Age 1.02 1.00 -1.03 0.049 
Gender ref: male    
Female 0.83 0.60 – 1.15  0.274 
Education ref: Less than HS    
HS 0.81 0.48-1.35 0.412 
Some College 1.25 0.84 – 1.85 0.270 
College Degree        1.89   1.06-3.38 0.031 
Marriage ref: Married    
Widowed 0.75 0.45 – 1.24 0.263 
Divorced or Separated  0.60 0.41 – 0.89 0.012 
Never Married or Cohabitating 0.87 0.56 – 1.34 0.528 
Income ref: <$12,000    
>=$12,000 1.03 0.75 – 1.41 0.867 
The TRUST Cohort  consists of 787 African Americans receiving care in an inner-city, safety-net setting 
that were diagnosed with hypertension. 
Medication adherence was defined by an adapted Morisky Adherence Scale. 
aThe John Henryism Scale ranges from 0-21  bThe Hall General TRUST scale ranges from 11-54. 
cPhysical and Mental Health Status obtained from the SF-12 survey. 
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Figure 3.2 Mediation Triangle for John Henryism and Medication Adherence 
 
Mediation Triangle
Direct Effect
Indirect Effect
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CHAPTER IV 
 
DOES THE USE OF HOME REMEDIES CONTRIBUTE TO 
LOW MEDICATION ADHERENCE AMONG AFRICAN 
AMERICANS WITH HYPERTENSION? 
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4.1 ABSTRACT 
 
Objectives: The prevalence and contributing factors of home remedy use among African 
Americans remains unclear. Patients taking antihypertensive medications may experience side 
effects from antihypertensive medications and turn to home remedies as an alternative to 
traditional medications. However, home remedies have not been proven as an effective treatment 
for hypertension. The objective of this study was to examine home remedy use among African 
Americans in the Deep South and to examine psychosocial and behavioral determinants of home 
remedy use. 
Methods: Study data were obtained from the Alabama Collaboration for Cardiovascular 
Equality, 2006-2008. Medication adherence was measured using the Morisky medication 
adherence scale, and home remedy use was self-reported by study participants.   Home remedy 
use was defined as using home remedies (yes or no), number of home remedies used, and type of 
home remedy used.  In multivariate models, covariates included general trust, age, gender, 
education, income, perceived hypertension severity, controlled hypertension, measures of blood 
pressure and self-efficacy.  Multivariate associations between home remedy use and mean 
arterial blood pressure were quantified using linear regression and ordinal logistic regression was 
used for multivariate associations between home remedy use and medication adherence. 
Results: Our sample consisted of 788 African Americans and 137 White participants with an 
average age of 53 years old. Adjusted analysis indicated the use of two or more home remedies 
was associated with poorer adherence to medication (OR: 0.54, p-value: 0.003). Increased self-
efficacy and higher perceived hypertension severity were also associated with better medication 
adherence. We also found significant associations between medication adherence, increased age, 
trust, education, and mean arterial blood pressure.  
Conclusion: Within our cohort of African Americans and Whites with hypertension greater 
home remedies use contributed to lower medication adherence. Participants reporting greater 
self-efficacy and greater perceived hypertension severity reported better adherence to 
medication. Participants reporting higher mean arterial pressure were more likely to be home 
remedy users. Our findings warrant further examination into the factors that influence home 
remedy use and the relationship between home remedies and adherence to prescribed 
medications. 
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4.2 Introduction 
  
The prevalence of home remedy use among African Americans is poorly understood. 
Home remedies are often used by African Americans in response to inadequate access to 
healthcare, mistrust of doctors, inability to afford medications, and having a family tradition of 
home remedy use.109 The National Survey of Black Americans (NSBA) indicated that 
approximately 35.4% of African Americans use home remedies to manage a condition.  
Additionally, 68% of the study participants of the NSBA reported that their families had a 
tradition of using home remedies to treat health conditions.45  
Home remedies typically refer to the use of garlic, mustard, vitamins, vinegar, teas and 
honey, and other treatments used to treat colds, burns, bruises, and chronic illnesses.110 
Individuals that use home remedies may do so as an alternative or a supplement to traditional 
treatments. However, most home remedies have not been proven effective treatment for 
managing chronic conditions such as hypertension. Home remedies may potentially be toxic for 
patients with hypertension and may interact with antihypertensive medications leading to adverse 
health events.111  Due to underreporting of home remedies, physicians and health care providers 
are not fully aware of how the use of home remedies interacts with traditional treatments.   
Typically, healthcare professionals discourage patients from using home remedies.112 As 
a result, home remedy users often feel stigmatized by healthcare professionals, and are less likely 
to report home remedy use.  This lack of communication between providers and patients results 
in an incomplete picture of the health profile of the patient; additionally, it increases the potential 
for mismanaging chronic conditions, such as hypertension.  Inadequate management of 
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hypertension puts these patients at increased risk of developing poorer health outcomes such as 
stroke, heart disease, and end-stage renal disease.  
Nearly one in three adults within the United States has hypertension. African Americans 
have the highest rates of hypertension in the world and the prevalence is steadily increasing.113  
African Americans typically have an earlier onset of hypertension, poorer health outcomes, and a 
more difficult time obtaining control of their condition.  To obtain control of hypertension, 
patients are encouraged to use a combination of diet, exercise, and adhere to antihypertensive 
medications. Each year, approximately 125,000 deaths from cardiovascular disease are attributed 
to medication nonadherence. Hypertension is an asymptomatic disease, yet, patients taking 
antihypertensive medications may report side effects which including headaches and dizziness, 
drowsiness, and frequent urination.51  Side effects from using antihypertensive medications may 
contribute to patients becoming nonadherent and seeking alternative treatments such as home 
remedies.  
Krousel-Wood et al assessed home remedy use among African Americans and Whites 
with high blood pressure.114 The study indicated that 30.5% of African Americans reported the 
use of complementary and alternative medicines (CAMs), a term often used to describe home 
remedy use, to treat high blood pressure. Their definition of CAMs included fish oil, fiber, L-
arginine, coenzyme Q10, garlic, and snakeroot. Within this sample, 18.4% African Americans 
reported low antihypertensive medication use, and African Americans reporting the use of 
CAMs were more likely to report low adherence to antihypertensive medications.  The authors 
suggested that their African Americans study participants were using CAMs as alternatives to 
their antihypertensive medications. These findings suggest that the use of home remedies may 
prevent patients from achieving hypertension control and correctly managing their condition. 
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Therefore, the overarching goal of this study was to examine the relationship between 
home remedy use and medication adherence among African Americans and Whites in the Deep 
South treated for hypertension in a safety-net setting. The primary objective of the study was to 
assess the prevalence and facilitators of home remedy use, including constructs such as perceived 
hypertension severity, self-efficacy, and trust.  The secondary objectives were to determine if the 
use of home remedies was associated with medication adherence and if home remedies were 
being used as a supplement or alternative to medication adherence.  
4.3 Methods 
4.3.1 TRUST Study Data and Sample 
 The TRUST study is a subproject within the Alabama Collaboration for Cardiovascular 
Equality (ACCE) project, 2006-2008.  The objectives of the TRUST study were to examine 
psychosocial and behavioral factors among African Americans with hypertension living in the 
Deep South.  Study participants were recruited from the Cooper Green Mercy Hospital System, 
in Birmingham, Alabama. The TRUST study was approved by IRBs at the University of 
Alabama at Birmingham and Cooper Green Mercy Hospital. Patient screening was conducted 
after obtaining local IRB approval and informed patient consent. The present study was approved 
by the IRB at the University of Massachusetts Medical School.  
 Survey data were collected through in-person interviews with interviewers trained and 
certified by the University of Alabama at Birmingham (UAB) Minority Health Research Center. 
Three certified study personnel used computer-assisted protocols to conduct in-person interviews 
and medical chart abstraction. Medical records were used to ascertain cardiovascular disease 
(CVD) risk factors, diagnoses, and findings related to end-stage organ damage associated with 
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CVD. Approximately 5% of medical records were dually abstracted with >95% reliability and 
validity agreement (inter-rater reliability).   
4.3.2 Inclusion/Exclusion Criteria 
 Eligible participants self reported race/ethnicity as African American or White, received 
primary care from Cooper Green Mercy Hospital, were diagnosed with hypertension, were 19 
years old or older, were able to provide informed consent, and were not pregnant.  Patients were 
excluded if they did not respond to questions regarding medication adherence and use of home 
remedies. 
4.3.3 Dependent Variable-Medication Adherence 
 The dependent variable for this study was self-reported medication adherence, measured 
using an adapted 4-item Morisky Medication Adherence Scale.115 The Morisky Medication 
Adherence Scale consist of the following questions: 1) “Do you ever forget to take your 
medicine?; 2) Are you careless at times about taking your medications?; 3) When you feel better 
do you sometimes stop taking your medicine?; and 4) Sometimes if you feel worse when you 
take the medicine do you stop taking it?”  Each item of the Morisky scale has a dichotomous 
(yes/no) response option with responses of yes or no adding 0 and 1 point respectively. The 
Morisky scale ranges from 0 to 4, with a lower score indicating worse adherence. For this study, 
we modified the Morisky scale by combining the two lowest adherence categories (0 and 1) and 
the two middle adherence categories (2 and 3).  Collapsing the categories produced a three level 
medication adherence variable. We modified the Morisky scale due to low cell counts in the 
lowest adherence categories.  Additionally, we reverse coded the scale so that higher scores were 
associated with lower adherence and for ease of interpretation. 
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The validity of the Morisky scale has been confirmed in several studies, including in 
studies with only African-American participants. The Morisky Scale was originally validated in 
a sample of 400 patients with hypertension, of which 91% were African American. The 
reliability of the Morisky scale was assessed using Cronbach’s alpha and produced a score of 
0.61. The Morisky scale has been previously validated in studies showing the scale is predictive 
for adherence to inhalers for asthma patients and also predictive for cardiovascular events.116,117   
4.3.4 Primary Independent Variable- Home Remedies 
 Home remedy use was assessed based on self-reported responses to the home remedies 
questionnaire developed by Brown et al.118   The Brown survey instrument was pretested on 20 
African Americans and whites with hypertension. We included the survey question “Besides 
prescription medicines, do you use anything else to treat your high blood pressure?” obtained 
from the Brown questionnaire.  The response options were a dichotomous yes/no response. An 
additional survey question regarding home remedy use was added to the survey including  “What 
home remedies do you use?” The options included vinegar, garlic, tea, mustard, vitamins, 
combinations, and other.   To obtain a measure of on the number of home remedies used, we 
summed the number of home remedies reported by each study participant.  
4.3.5 Secondary Independent Variables 
To explore the use of home remedies the following secondary independent variables were 
assessed in this study.  Measures of self-reported socioeconomic status included income, 
education and difficulty paying for medical care.  Income was categorized as: <$25,000 and >= 
$25,000; education was divided into four categories; less than HS, HS, some college, college 
degree, and the variable of difficulty paying for medical care was categorized as not hard, 
somewhat hard, hard, very hard. Demographic variables of gender, race, and age were also 
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included, as were sociocultural factors such as self-efficacy for medication adherence and trust in 
physicians.8,119 The Medication Adherence Self-Efficacy Scale is a 26-item scale that assesses 
patient’s self-efficacy in adhering to medications.  The Medication Adherence Self-Efficacy 
scales uses a three-point response with 1= not sure at all 2= somewhat sure, and 3= very sure. 
Trust was measured using the Hall General Trust Scale, which ranges from 11 to 54 with a 
higher score indicating greater trust.   The Hall General trust scale represents four domains of 
trust 1) fidelity (caring and conflict of interest) 2) competence (technical and interpersonal); 3) 
honesty; and 3) global.  We also included a measure to assess the perceived severity of 
hypertension, which ranges from 0-14 (a higher score indicates greater perceived severity) and 
controlled hypertension. Lastly, to assess the effects of home remedy use on hypertension, we 
included measures of blood pressure, systolic blood pressure, diastolic blood pressure, and  mean 
arterial pressure. 
4.3.6. Statistical Analysis 
The characteristics of the study sample and assessment of factors associated with home 
remedy use was obtained using ANOVA assessed statistically significant differences in groups 
for continuous variables and chi-square for the categorical variables.  For the analysis of home 
remedy use bivariate analysis was conducted using ANOVA and chi-square. To assess the 
adjusted association between home remedy use and medication adherence ordinal logistic 
regression was used, the model was adjusted for gender, age, general trust, income, education, 
self-efficacy, hypertension control, and perceived hypertension severity. To assess the 
association of mean arterial pressure with medication adherence and blood pressure we used a 
linear regression model.  The model was adjusted for gender, age, general trust, income, 
education, self-efficacy, perceived hypertension severity, and medication adherence. Relatively 
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few White participants reported home remedy use. Therefore, we excluded White participants 
from the multivariate analysis of the home remedy use, multivariate analysis of medication 
adherence, and the bivariate and multivariate analysis of mean arterial pressure.  Statistical 
analysis was conducted using STATA version 12 (StataCorp, College Station, TX).  
4.4 Results 
 Our sample included of 788 African Americans and 137 Whites with an average age of 
53 years old. Approximately 70% of our study participants were women. Sixty-seven percent of 
the participants reporting attending some college or obtaining a college degree; however, 94% 
reported an annual household income of less than $25,000.   
Table 1 describes the study participants by race/ethnic group. We found statistically 
significant differences in rates of controlled hypertension: systolic blood pressure, diastolic blood 
pressure, and mean arterial pressure. Twenty-three percent of the African-American participants 
reported controlled hypertension compared to 42.65% among the white study participants (p= 
<0.001). General trust in healthcare was statistically (mean; SD) different between African-
American (39.15; 7.96) and White participants (37.01; 8.42) (p=0.004). African Americans 
reported higher scores for perceived hypertension severity (6.89; 2.04) compared to their White 
counterparts (7.26; 2.11) (p=0.018). African American also reported lower adherence and greater 
use of home remedies than Whites. We found no significant differences in age, gender, 
education, income, self-efficacy between African Americans and Whites.  
4.4.1 Bivariate Associations of Home Remedy Use among African Americans and Whites 
 In Table 2, we present the differences between home remedy users and nonusers stratified 
by race/ethnic group. Among White participants, we found significant differences between 
perceived hypertension severity scores among home remedy users (6.45) and nonusers (7.46).  
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Also white participants that used home remedies reported lower trust 32.95 compared to 
nonusers 37.68. Among African Americans, home remedies users had higher systolic, diastolic, 
and mean arterial pressure than individuals that did not use home remedies. African Americans 
that reported home remedy use reported more low adherence 21.10% compared to nonusers at 
11.76%.  African Americans who did not use home remedies reported better self-efficacy (64.28) 
compared to users (62.15).  
4.4.2 Home Remedy Use among African Americans 
 In Table 4.3, we assessed home remedy use among African Americans.  In the bivariate 
analyses, there was a statistically significant relationship between home remedy use and 
perceived hypertension severity (OR: 0.90, CI: 0.84-0.98) and self-efficacy (OR:0.98 CI: 0.96-
0.99).  However, the association did not persist between perceived hypertension severity and 
home remedies in the multivariate model. However, self-efficacy and home remedies remained 
statistically significant in the multivariate model. No other statistically significant associations 
were found.  
4.4.3 Medication Adherence and Home Remedy Use 
 The results of multivariate analysis indicated an association between home remedy use 
and medication adherence among African Americans.  The findings from the multivariate 
analysis are presented in Table 4.4.  We present three models for this analysis.  Model 1 presents 
the unadjusted association of home remedy use and medication adherence, Model 2 includes 
home remedy use and the demographic factors, and Model 3 includes home remedy use, 
demographic factors and the psychosocial factors of trust and self-efficacy.  In the fully adjusted 
model, we found a statistically significant (p=0.003) relationship between low medication 
adherence and home remedy use (OR: 0.54 CI: 0.36-0.81) when participants were using 2 or 
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more home remedies. Age (1.02; 1.01-1.04) was significantly associated with better medication 
adherence (p=<0.001). Both greater trust and greater self-efficacy were significantly associated 
with better medication adherence.  However, no significant relationships were found between 
gender, education, or income.  
4.4.4 Mean Arterial Pressure in African Americans 
 In Table 4.5, we present the results of the analysis of mean arterial blood pressure and 
home remedy use.  Our findings indicated that use of two or more home remedies was associated 
with higher mean arterial blood pressure. However, the association between mean arterial 
pressure and use of one home remedy did not persist in the multivariate model.  The use two or 
more home remedies was significantly associated with greater mean arterial blood pressure 
(p=0.005).  We also found that age and perceived hypertension severity were associated with 
mean arterial pressure in both bivariate and multivariate models.  
4.5 Discussion  
Within our sample of African Americans and Whites with hypertension receiving care at 
a safety-net hospital in the inner city, approximately 28% of the African-American participants 
reported using 1 or more home remedies. On average African Americans had higher systolic, 
diastolic and mean arterial blood pressure than Whites.  African Americans also reported greater 
trust healthcare providers and use of home remedies. White participants reported greater 
perceived severity of hypertension and reported better adherence to medication.  As we 
hypothesized, more reported use of home remedies was linked with poorer medication adherence 
suggesting patients might be using home remedies as an alternative to medication. We found that 
the use of two or more home remedies was associated with poorer medication adherence as well 
as higher mean arterial blood pressure. Our findings suggest that, among African American study 
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participants home remedy use may serve as substitute for medication adherence and result in 
higher blood pressure. Our study expands on the existing literature by examining social factors 
such as self-efficacy, perceived hypertension severity, and trust.  These factors showed 
statistically significant associations with home remedy use, medication adherence, and mean 
arterial blood pressure.  To our knowledge, we are the first to examine these constructs within 
the context of a home remedies study.    
Our findings are consistent with the existing literature of home remedy use. In a study by 
Brown et al., African Americans living within the poverty threshold and with less than a high 
school education were more likely to use home remedies.118 Boyd et al. found a variety of factors 
that were associated with increased use of home remedies: greater religiosity, residing with a 
grandparent as a child or teen, rural residence, and region of residency.45  Brown et al. conducted 
a study of 300 African Americans and Whites.  The African-American participants in their study 
had stronger beliefs in the benefits of home remedies than Whites.120  The authors concluded that 
African Americans were less compliant with medications and more likely to use home remedies 
than the White study participants. Similarly, a study by MacKenzie et al. of 3,789 found 35% of 
their sample reported using complimentary or alternative medicine.  African Americans were 
1.24 times more likely to use of home remedies than whites.121 Lastly, Frate et al. conducted a 
study of home remedy use among patients in Mississippi; approximately 71% of their 
participants reported using home remedies including lemon, castor oil, and garlic to treat 
conditions such as respiratory symptoms, cardiovascular symptoms and gastrointestinal 
problems.122  
However, other studies of home remedy use have found dissimilar findings. For example, 
in a study by Brown et al. African Americans with higher education and higher income were 
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more likely to use CAMs.  However, the researchers defined CAM use, as services such as 
chiropractic care, relaxation treatment, medication and psychological treatments, which differ 
from the definition of home remedies used in the present study.123  A similar study by Mackenzie 
et al. assessed CAM use among White, Black, Latino, Asian and Native American participants.  
They defined CAM use as herbal medicine, acupuncture, chiropractic, and home remedies. 
While African Americans reported greater use of home remedies, they were less likely to use 
other forms of CAMs such as acupuncture and chiropractic services. 
4.5.1 Strengths/Limitations 
 There are several strengths to our assessment of home remedy use.  The large study 
sample consisted of African-American participants recruited from an inner city, safety-net 
hospital. Additionally, we collected data on psychosocial and behavioral factors that have rarely 
been examined in such a setting. However, the study has limitations worth acknowledging.  First, 
it is a cross-sectional analysis, and causality cannot be determined. The findings of the study 
reflect only participant responses at one point in time, thus we cannot determine changes in home 
remedy use and medication adherence over time. The findings of our study may not be 
generalizable to other racial/ethnic groups and other regions across the United States.  Third, we 
did not examine home remedies other than foods, thus home remedies such as Chinese herbs and 
relaxation techniques were not included. Finally, while the instruments used for the study were 
validated measures, all were self-reported increasing the likelihood of recall bias and errors in 
recall of behaviors.  Due to the stigmatization of home remedy use it is also possible that patients 
may underreport the use of home remedies. Self-report of medication adherence may also be 
limited as patients may provide socially desirable answers and over report adherence to 
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medications. However, it is important to note that some items such as self-efficacy, trust, and 
home remedy use are best ascertained by self-report.  
4.5.2 Implications  
Home remedy use in the United States is poorly understood, partially due to 
underreporting by patients. While our findings highlight several factors that contribute to home 
remedy use, researchers as well as physicians need a more in-depth understanding of other 
drivers of home remedy use. Open and candid discussions about home remedy use between 
patients and providers may provide healthcare providers with opportunities to educate patients 
about home remedy use and teach patients how to appropriately manage their condition.  
Perceived hypertension severity may be an area for future intervention, as patients that are less 
likely to perceive hypertension as serious are perhaps more likely to turn to home remedies.  
Additionally, self-efficacy may provide another avenue for intervention, patients that report high 
levels of self-efficacy appear to be more engaged in managing their condition.  Designing 
interventions and tailoring them for individuals that have low self-efficacy or perceive 
hypertension as less severe may bolster the effectiveness for existing interventions.  
4.5.3 Conclusion 
The findings of this research highlight the importance of psychosocial constructs as they 
relate to home remedy use.  Our findings contribute to the existing evidence by incorporating the 
constructs of hypertension severity, medication adherence self-efficacy, and trust into our 
analysis and identifying important associations between these constructs and home remedy use.  
Home remedies interventions that educate patients, encourage physician education, and promote 
training in cultural sensitivity, and provide a greater understanding of the population most likely 
to engage in home remedy use are likely to be the most effective in promoting behavioral change 
  
82 
 
among home remedies users.  Having open and candid discussions about home remedy use may 
provide opportunities to educate patients about home remedy use and teach patients how to 
appropriately manage their condition.  Additionally, tailoring interventions for individuals with 
low self-efficacy or perceive hypertension as less severe may bolster the effectiveness of existing 
interventions.  It is our hope that this study provides a foundation for future interventions as well 
as a better understanding of the population that uses home remedies and the health outcomes and 
health behaviors associated with home remedies use.  
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Table 4.1: Characteristics of the African American and White Participants with 
Hypertension in the TRUST Study, 2007-2008 
Demographic African 
American n=788 
White 
n=137 
p-value 
Age, mean (SD) 53.67 (9.83) 53.47 (8.73) 0.676 
Female, n (%) 558 (70.90) 89 (65.44) 0.199 
Education, n (%)   0.594 
Less than HS 136 (17.28) 34 (25.00)  
High School 114 (14.49) 13 (9.56)  
Some College 461 (58.58) 72 (52.94)  
College Degree 76 (9.66) 17 (12.50)  
Annual Household Income less than 
$25,000, n (%) 
  0.799 
No 249 (34.06) 43 (35.25)  
Yes 482 (65.94) 79 (64.75)  
Controlled Hypertension, n (%) 182 (23.13) 58 (42.65) <0.001 
Trust in Physicians, mean (SD)a 39.15 (7.96) 37.01 (8.42) 0.004 
Self-efficacy, mean (SD)b 63.66 (9.06) 64.75 (9.42) 0.138 
Perceived Hypertension Severity, 
mean (SD) 
6.89 (2.04) 7.26 (2.11) 0.018 
Morisky Medication Adherence, 
n(%) 
  <0.001 
Low Adherence 112 (14.36) 8 (6.06)  
Moderate Adherence 350 (39.39) 52 (44.87)  
High Adherence 318 (54.55)  72 (40.77)  
Home Remedy Use, n(%)   <0.001 
Yes 219 (27.86) 20 (14.71)  
Type of Home Remedies Used, n(%)    
Vinegar 153 (19.42) 2 (1.46) <0.001 
Garlic  91 (11.55) 6 (4.38) 0.315 
Mustard 45 (5.71) 0 (0.00) 0.004 
Teas 37 (4.70) 5 (3.65) 0.363 
Vitamins 21 (2.66) 7 (5.11) <0.001 
Honey 7 (0.89) 0 (0.00) 0.268 
Number of Home Remedies Used, 
n(%) 
  <0.001 
0 578 (73.35) 121 (88.32)  
1 96 (12.18) 13 (9.49)  
2 or more 114 (14.47) 3 (2.19)  
Systolic Blood Pressure, mean (SD) 149.57 (19.57) 140.60 (17.21) <0.001 
Diastolic Blood Pressure, mean (SD) 82.13 (11.93) 76.75 (10.96) <0.001 
Mean Arterial Pressure, mean (SD) 104.61 (13.26) 98.03 (11.64) <0.001 
aTrust was measured using the Hall General Trust Scale, which ranges from 11 to 55 with a higher score indicating greater trust. bSelf-
efficacy was measured using the Ogedegbe Medication Adherence Self-Efficacy scale. The scale ranges from 1 to 78, with a higher 
score indicating greater self-efficacy. Hypertension control was defined as having systolic blood pressure lower than 120 and diastolic 
blood pressure under 80.  
Table 4.2  Factors associated with Use of Home Remedies among African American and White TRUST Study participants, 
2007-2008 
 African-Americans n=788 Whites n=137 
 Home 
Remedies Use 
No Home 
Remedies Use 
p-value Home 
Remedies Use 
No Home 
Remedies Use 
p-value 
Medication Adherence, (%)   0.004   0.712 
Low Adherence 46 (21.10) 66 (11.76)  2 (10.00) 6 (5.41)  
Moderate Adherence 91 (41.74) 258 (45.99)  7 (35.00) 44 (39.64)  
High Adherence 81 (37.16) 237 (42.25)  11 (55.00) 61 (54.95)  
Systolic Blood Pressure, Mean (SD) 152.79 (21.15) 148.27 (18.81) 0.004 142.23 (15.57) 140.41 (17.59) 0.665 
Diastolic Blood Pressure, Mean 
(SD) 
84.10 (12.13) 81.39 (11.78) 0.005 78.11 (12.29) 76.52 (10.80) 0.551 
Mean Arterial Pressure, Mean 
(SD) 
107.00 (14.02) 103.69 (12.88) 0.002 99.49 (11.96) 97.82 (11.67) 0.557 
Perceived Hypertension Severity, 
Mean (SD) 
6.60 (2.13) 6.98 (1.98) 0.017 6.45 (2.54) 7.46 (1.90) 0.040 
Age, Mean (SD) 53.32 (9.46) 53.76 (9.93) 0.565 54.50 (7.31) 53.38 (8.95) 0.597 
Self Efficacy, Mean, (SD) 62.15 (9.39) 64.28 (8.84) 0.003 62.75 (13.03) 65.08 (8.71) 0.311 
Trust in Physicians, Mean (SD) 38.86 (7.91) 39.26 (7.98) 0.532 32.95 (9.30) 37.68 (8.14) 0.020 
Gender, (%)   0.505   0.964 
Male 60 (27.40) 169 (29.81)  7 (35.00) 40 (34.48)  
Female 159 (72.60) 398 (70.19)  13 (65.00) 76 (65.52)  
Annual Household Income less 
than $25,000, (%) 
  0.133   0.375 
No 61 (29.76) 187 (35.62)  5 (26.32) 38 (36.89)  
Yes 144 (70.24) 338 (64.38)  14 (73.68) 65 (63.11)  
Education, (%)   0.590   0.415 
Less than HS 34 (15.53) 102 (17.99)  3 (15.00) 31 (26.72)  
HS 37 (16.89) 76 (13.40)  1 (5.00) 12 (10.34)  
Some College 127 (57.99) 334 (58.91)  14 (70.00) 58 (50.00)  
College Degree 21 (9.59) 55 (9.70)  2 (10.00) 15 (12.93)  
  
85 
 
 
 
Table 4.3. Bivariate and Multivariate analysis of Home Remedy use among the 726African 
American Participants in the TRUST study, 2007-2008. 
 Bivariate Analyses Multivariate Analyses 
 Odds 
Ratio  
95% 
Confidence 
Interval 
p-
value 
Odds 
Ratio  
95% 
Confidence 
Interval 
p-
value 
Female 1.09 0.77 – 1.53 0.627 1.06 0.73 – 1.54 0.762 
Age 1.00 0.98 – 1.01 0.549 1.00 0.99 – 1.02 0.816 
Trust in Physicians 1.00 0.98 – 1.01 0.614 1.00 0.98 – 1.02 0.903 
Annual Household Income 
less than $25,000 
0.72 0.36 – 1.44 0.357 0.86 0.42 – 1.76 0.675 
Education (ref: Less than 
HS) 
      
High School 1.41 0.82 – 2.42 0.211 1.30 0.73 – 2.31 0.375 
Some College 1.09 0.71 – 1.67 0.705 1.09 0.69 – 1.71 0.726 
College Degree 1.18 0.64 – 2.18 0.599 1.27 0.65 – 2.46 0.487 
Self-efficacy 0.98 0.96 – 0.99 0.008 0.98 0.96 – 1.00 0.042 
Perceived Hypertension 
Severity 
0.90 0.84 – 0.98 0.009 0.94 0.86 – 1.02 0.131 
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 Table 4.4 Multivariate Model of the Association between Reported Home Remedy Use and Better Medication Adherence among the 532 
African American Participants of the TRUST Study, 2007-2008 
 Model 1: Unadjusted Model 2: Demographic Factors Model 3: Psychosocial Factors 
 OR 95% CI p-value OR 95% CI p-value OR 95% CI p-values 
Home Count (ref: None used)          
1 1.04 0.69 – 1.54 0.670 1.08 0.72- 1.63 0.717 1.27 0.83- 1.94 0.266 
2 or more 0.56 0.39 – 0.83 0.002 0.52 0.35- 0.77 0.001 0.54 0.36- 0.81 0.003 
Age    1.02 1.01-1.04 <0.001 1.02 1.01-1.04 0.001 
Gender (ref: male)          
Female     0.77 0.59-1.03 0.083 0.82 0.61-1.09 0.173 
Education (ref: less than HS)          
HS    0.80 0.50-1.25 0.317 0.80 0.50-1.29 0.355 
Some College    1.15 0.81-1.63 0.432 1.10 0.77-1.58 0.592 
College    1.54 0.93-2.56 0.093 1.51 0.88-2.57 0.134 
Annual Household Income (less 
than $25,000) 
         
>=$25,000    1.14 0.66-1.97 0.638 0.88 0.51-1.54 0.651 
Trust in Physicians       1.02 1.01-1.04 0.006 
Self-efficacy        1.09 1.08-1.11 <0.001 
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Table 4.5 Mean Arterial Pressure and Home Remedy Use among the 728 African American 
Participants of the TRUST Study, 2007-2008 
 Bivariate Associations Multivariate Associations 
 Coef. 95% 
Confidence 
Interval 
p-value Coef. 95% 
Confidence 
Interval 
p-value 
Home Remedies (ref: none)       
1 3.17 0.31 – 6.03 0.030 2.52 -.45 – 5.49 0.097 
2 or more 3.53 0.88 – 6.18 0.009 2.77 -0.00 – 5.54 0.050 
Female -1.71 -3.75 – 0.34 0.012 -1.14 -3.32 – 1.05 0.308 
Age -0.24 -0.33 - -1.45 <0.001 -0.19 -0.29 - -0.09 <0.001 
Education (ref: Less than HS)       
High School 2.15 -1.13 – 5.43 0.199 1.40 -2.02 – 4.83 0.421 
Some College 2.93 0.39 – 5.47 0.023 1.92 -0.74 – 4.59 0.156 
College Degree 3.60 -0.14 – 7.33 0.059 2.35 -1.58 – 6.27 0.241 
Annual Household Income 
Less than $25,000 (ref: no) 
      
Yes 3.02 -0.97 – 7.02 0.138 2.76 -1.25 – 6.78 0.177 
Trust in Physicians -0.94 -0.21 – 0.22 0.112 -0.50 -0.18 – 0.08 0.441 
Self-efficacy -0.05 -0.15 – 0.05 0.315 0.02 -0.10 – 0.14 0.759 
Perceived Hypertension 
Severity 
-0.87 -1.31 - -0.41 <0.001 -0.65 -1.14 – 0.16 0.009 
Morisky Medication 
Adherence (ref: Low) 
      
Moderate -2.85 -5.68 - -0.02 0.048 -1.94 -5.06 – 1.18 0.223 
High 3.24 -6.11 – 0.37 0.027 -2.10 -5.48 – 1.28 0.223 
Linear regression was used for bivariate and multivariate analyses.    
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CHAPTER V 
 DISCUSSION AND CONCLUSION 
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5.1 Summary   
 The purpose of this dissertation was to examine selected psychosocial and behavioral 
constructs as potential barriers to medication adherence.  We examined these constructs within a 
cohort of African Americans with hypertension that were receiving care at a safety-net setting in 
Birmingham, Alabama. This research assessed low adherence within a population at the greatest 
risk of developing complications from uncontrolled hypertension. African Americans with 
hypertension often have a more difficult time controlling their blood pressure.124 Many of the 
existing studies that have attempted to promote better adherence to medication have focused 
exclusively on the economic barriers to adherence, yet these studies have been unable to provide 
a comprehensive understanding of the barriers to adherence.125  Additionally, these studies have 
only been moderately effective in improving long-term adherence to medications. Psychosocial 
and behavioral factors may be the key to bolstering the effectiveness of medication adherence 
interventions. The findings from this study highlight the importance of psychosocial and 
behavioral factors as determinants of medication adherence, including rarely examined 
predictors such as racial discrimination, trust, John Henryism, and home remedy.  
In the first aim we explored the relationship between reported racial discrimination and 
medication adherence.  Within our sample of African Americans with hypertension those 
reporting more experiences of race-based discrimination also reported poorer adherence to 
medication. These findings hold particular importance for our study sample.  The city of 
Birmingham, Alabama the setting for our study was instrumental during the Civil Rights 
Movement.  The majority of our study participants were born and raised in Birmingham, and 
likely lived during the height of the Civil Rights Era. Our study participants did not report high 
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levels of racial discrimination, we suspect that our participants current experiences of 
discrimination may seem mild by comparison to their experiences during the Civil Rights Era 
(1950-1960s).  Thus, these patients may report less discrimination.  Other studies have shown 
that older African Americans report less discrimination than younger African Americans.39   It is 
likely these patients may have a higher threshold of what constitutes race-based 
discrimination.126 Additionally, experiencing racial discrimination has been linked with lower 
utilization of the healthcare system and poorer compliance to physician recommendations and 
treatments.127 Perhaps the patients in our study sample that experienced discrimination are less 
likely to follow the instructions of their physician. Preventing discriminatory behaviors seems to 
be a daunting task; however, promoting discussions about past experiences of discrimination and 
providing suggestions to patients for methods of coping may help patients overcome these 
experiences.  Patients that have a healthier way of coping with such experiences are probably 
more likely to be engaged in the healthcare system and more likely to adhere to the instructions 
of their healthcare providers. 
In the first aim, we also examined the role of trust as a mediator between reported 
discrimination and medication adherence.  Study participants that reported more racial 
discrimination reported lower trust in the healthcare system and physicians and these patients 
reported lower adherence to medications. Approximately 39% of the association between 
reported racial discrimination and medication adherence was explained by trust in the healthcare 
system. It is likely that within our study participants these findings highlight the fragile 
relationship between African Americans and the healthcare system.  This may be partially due to 
historical examples of mistreatment towards African Americans when seeking care from the 
medical system. These examples of mistrust and discrimination when seeking healthcare may 
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continue to affect the health behaviors and health outcomes for African American patients.71,72,128  
However, expanding existing research to incorporate these factors into future studies is likely to 
improve the patient-provider relationship and build greater trust within the African American 
community. 
The second aim of the dissertation assessed John Henryism, a measure of active coping 
and medication adherence among the African American participants in the TRUST study 
cohort.33 The folktale of John Henry serves as the inspiration for the concept of John Henryism. 
Similar to John Henry, the legendary steel driver, individuals reporting high John Henryism 
possess an unrelenting desire to be the best and to work against all odds even in the presence of 
great adversity.  Sherman James crafted the John Henryism hypothesis and suggested that the 
combination of social and environmental stressors (such as discrimination) combined with low 
socioeconomic status and a lack of resources that contributes to the adverse health outcomes 
found among individuals reporting high levels of John Henryism.85,129  
 Several studies have linked John Henryism with hypertension, yet relatively few studies 
have examined John Henryism with health related behaviors. In our African American cohort, 
higher John Henryism was associated with lower adherence to medication. John Henryism is an 
excessive behavioral response to stressful experiences such as discrimination and differential 
treatment. Thus, individuals reporting higher John Henryism are more likely to have a 
heightened physiological and psychological reaction to stressors. As a result these individuals 
may access and utilize healthcare services less frequently or be disengaged from the medical 
system leading to maladaptive health behaviors.   
Participants reporting higher John Henryism also reported lower trust and poorer 
medication adherence. We examined the role of trust as a mediator of this association, and found 
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24% of this association was explained by trust. We suspect that individuals reporting high John 
Henryism have more of a reactive personality (in the face of challenges they are likely to take 
action).  Therefore, these individuals that are less trusting and report high John Henryism may be 
more likely to turn to self-care rather than follow the instructions of their healthcare providers 
and physicians.  
In the final aim of this dissertation, we examined home remedy use among African 
Americans and Whites. African Americans reported greater home remedy use.  However, in 
addition to using more home remedies, these same individuals had higher rates of uncontrolled 
hypertension and higher blood pressure. There were also difference in terms of users and 
nonusers of home remedies. African American home remedy users reported lower adherence, 
poorer self-efficacy, and higher blood pressure than non-home remedies users.  However, White 
study participants users reported lower trust in healthcare providers. Home remedy use was also 
associated with higher mean arterial pressure. These findings suggest that participants may be 
using home remedies as an alternative to traditional treatments. Better medication adherence was 
also associated with greater self-efficacy and higher perceived hypertension severity.  These 
findings add to the existing literature regarding home remedy use and highlight rarely examined 
constructs such as self-efficacy and perceived hypertension severity among home remedy users. 
These constructs may potentially be incorporated into interventions, and these interventions can 
be tailored for individuals with low self-efficacy and low perceived hypertension severity to 
bolster the effectiveness of medication adherence interventions.   
This dissertation research has provided greater insights to the issue of medication 
nonadherence within the African American community.  The issue of nonadherence is a 
multifaceted issue that cannot simply be attributed to the inability to afford medications.  The 
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findings from the present study have provided the foundation for future research that will expand 
on the psychosocial and behavioral factors included in this study but will continue to explore 
factors such as stress, spirituality, and happiness as predictors of medication adherence. The 
existing evidence suggests that the most effective interventions for promoting medication 
adherence are multidimensional and incorporate several techniques for promoting adherence. 
Interventions that incorporate trust, discuss home remedies use, and discuss past experiences that 
affects adherence and utilization of the healthcare system may help improve medication 
adherence among African Americans. The next steps for this research will be to incorporate the 
constructs explored in this research into existing interventions to promote behavioral change 
among African Americans with hypertension.  Lastly, the findings from this study will be used to 
develop a conceptual model that best illustrates the association between the social constructs 
explored in this research and will hopefully provide a guide for researchers examining 
psychosocial and behavioral determinants of medication adherence.    
5.2 Strengths and Limitations 
We present novel findings related to medication adherence in African Americans and 
there are several strengths in the design of this study that are worth noting. First, we examined 
psychosocial and behavioral factors among African Americans, individuals of low income and 
low resources, and those living in the Deep South, the population at the greatest risk for poorer 
health outcomes. Our findings provide greater insights into the barriers to appropriate 
hypertension management and provide suggestions for future studies that examine similar social 
constructs.  Our cross-sectional analysis provides a foundation for longitudinal research that will 
assess predictors of medication adherence.  However, we must also acknowledge the overall 
limitations of this study.  Our study used observational data. Although observational data cannot 
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answer questions of causality, it can potentially help elucidate root causes of health disparities 
and point towards areas for future research. Next, all variables of interest were self-reported by 
the participants, which may potentially result in recall bias. Additionally there may be selection 
bias as those who decided to participate may be different from the general population.  
5.3 Implications 
The present study adds to the existing studies of social and behavioral factors and 
contributes to a better understanding of the barriers to medication adherence.  This information is 
an asset to healthcare providers that often may not know the causes of nonadherence among their 
patients.  By better understanding the cultural traditions and how life experiences may affect 
decision making these providers may better understand their patient population.   Incorporating 
psychosocial and behavioral constructs into existing medication adherence interventions may 
hold untapped potential for promoting behavioral change. We suggest several techniques to 
enhance existing medication adherence interventions, including promoting a trusting patient-
provider relationship, addressing past issues of racial discrimination, and facilitating 
communication between patients and physicians about alternative treatments. These suggestions 
are likely to improve the patient provider relationship and may contribute to a more 
comprehensive understanding between patient and provider.  While encouraging long term 
behavioral change for patients is difficult, promoting moderate change in individuals with 
hypertension may contribute to better hypertension management and ultimately reduce the health 
disparities found among African Americans with hypertension. 
D. Final Conclusions 
 It is our hope that this research has provided greater insight to the barriers to medication 
adherence among African Americans with hypertension. This study has generated a wealth of 
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new knowledge about the root causes of cardiovascular health disparities, which is a topic of 
urgent public health need.  Disparities continue to exist and continue to affect the health of 
African Americans.  However, in order to make improvements on health of African Americans 
we must truly understand the determinants of health disparities and the factors that contribute to 
the poorer health outcomes seen in underserved and vulnerable populations.  
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APPENDIX A. THE JOHN HENRYISM SCALE OF ACTIVE COPING (JHAC12) 
1. I’ve always felt that I could make of my life pretty much what I wanted to make of it. 
2. Once I make up my mind to do something.  I stay with it until the job is completely done.  
3. I like doing things that other people thought could not be done. 
4. When things do not go the way I want them to, that just makes me work even harder. 
5. Sometimes I feel that if anything is going to be done right, I have to do it myself. 
6. It is not always easy, but I manage to find a way to do the things I really need to get done. 
7. Very seldom have I been disappointed by the results of my hard work. 
8. I feel that I am the kind of individual who stands up for what he believes in, regardless of the 
consequences. 
9. In the past, even when things got really tough, I never lost sight of my goals. 
10. It is important for me to be able to do things the way I want to do them rather than the way other 
people want me to do them. 
11. I do not let my personal feelings get in the way of doing a job. 
12. Hard work has really helped me get ahead in life. 
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APPENDIX B- TRUST QUESTIONNAIRE  
ALABAMA COLLABORATION OF CARDIOVASCULAR EQUITY 
TRUST PATIENT SURVEY 
 
Hello.  My name is _________________.  Thank you for your participation and time.  Your 
thoughts are important to us.  This is the project I had spoken to you about previously.  I need to 
tell you a few things about it before we begin.  This may take a few minutes.  We are doing a 
project on hypertension or high blood pressure.  I will ask you many questions that deal with all 
aspects of life.  Some may not be related to health, but we want to get the big picture.  I want you 
to talk about your experience with doctors and what it’s like to live with high blood pressure.  
You have been invited to participate in this project because your doctor has diagnosed you with 
high blood pressure.  Based on the feedback you give us, we hope to develop programs that will 
be beneficial to you and other patients.  There is no right or wrong answer to these questions.  
Your participation in this project does not involve any sort of medical tests or treatment.  Taking 
part in this project is voluntary.  You do not have to participate, you do not have to answer any 
question you do not want to answer, and you can stop at any time for any reason. 
 
The information gathered during this conversation will be kept confidential.  This means that if 
we publish the findings based on your answers, your name or any other information that 
describes you as an individual will not be included.  If you like, you can receive a copy of the 
findings of this project and/or discuss the project with a staff person.  You will receive a $25 gift 
card as a token of our appreciation and to thank you for your participation. 
 
This survey should take about an hour to an hour and a half to complete.  Do you have any 
questions before we begin? 
 
1. Is it true that your doctor has diagnosed you with hypertension or high blood pressure? 
 
1.    Yes  CONTINUE INTERVIEW 
2.     No  THANK YOU and STOP INTERVIEW 
 
Has a doctor or nurse ever said that you have.. 
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2. High blood cholesterol?  
0.  Not sure 
1.  Yes  At what age were you first told this? ____ years 
2.  No 
 
3. Heart problems?  
0.   Not sure 
1.    Yes  What type?     Age first told? 
  Heart attack      2 = No 1 = Yes ______ years  
  Angina     2 = No 1 = Yes ______ years  
  Rheumatic heart disease   2 = No 1 = Yes ______ years  
  Mitral valve prolapse    2 = No 1 =Yes    ______years  
  Other _______________    2 = No 1 = Yes ______ years  
2.    No 
 
4. Diabetes (high sugar in blood or urine)?  
 0.  Not sure 
  1.  Yes  At what age were you first told this? _______ years  
    2.  No 
 
5. Peripheral vascular disease (problems with circulation, blocked arteries to the legs)?  
0.   Not sure 
1. Yes  At what age were you first told this? _______ years  
2. No 
 
6. Stroke or TIA (Transient Ischemic Attack)?  
0.    Not sure 
1.    Yes  At what age were you first told this? _______ years  
2.    No 
 
HEALTH STATUS (SF-12) 
 
I would like to ask you some questions about your health. 
 
7. In general, would you say your health is (circle one answer)  
1.   Excellent 
2. Very Good 
3. Good 
4. Fair 
5. Poor 
 
The following items are about activities you might do during a typical day.  
 
Does your health now limit you in these activities?  If so, how much? 
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8. Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing 
golf  
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
9. Climbing several flights of stairs  
1. Yes, limited a lot 
2. Yes, limited a little 
3. No, not limited at all 
 
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health? 
 
10. Accomplished less than you would like  
0.   UTD 
1.   Yes 
2.   No 
 
11. Were limited in the kind of work or other activities  
   0.   UTD 
1. Yes 
2. No 
 
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (such as feeling depressed or 
anxious)? 
 
12. Accomplished less than you would like  
0.   UTD 
1.   Yes 
2.   No 
 
13. Didn’t do work or other activities as carefully as usual   
0.   UTD 
1.   Yes 
2.   No 
 
 
14. During the past 4 weeks, how much did pain interfere with your normal work (including both 
work outside the home and housework)?  
1. Not at all 
2. A little bit 
3. Moderately 
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4. Quite a bit 
5. Extremely 
 
These questions are about how you feel and how things have been with you during the past 4 
weeks. For each question please give the one answer that comes closest to the way you have 
been feeling.  [Show patient YELLOW CARD.] 
 
How much of the time during the past 4 weeks: 
 
15. Have you felt calm and peaceful?  
1. All of the time 
2. Most of the time 
3. A good bit of the time 
4. Some of the time 
5. A little of the time 
6. None of the time  
 
16. Did you have a lot of energy?  
1. All of the time 
2. Most of the time 
3. A good bit of the time 
4. Some of the time 
5. A little of the time 
6. None of the time  
 
17. Have you felt downhearted and blue?  
1. All of the time 
2. Most of the time 
3. A good bit of the time 
4. Some of the time 
5. A little of the time 
6. None of the time  
 
18. During t he past 4  w eeks, how  m uch of  t he t ime ha s your physical h ealth o r em otional 
problems interfered with your social activities (like visiting with friends, relatives, etc.)?  
1. All of the time 
2. Most of the time 
3. A good bit of the time 
4. Some of the time 
5. A little of the time 
6. None of the time  
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PATIENT SATISFACTION (PSQ-III short version) 
 
These next questions address your experiences with receiving health care.  We realize that you 
may see many doctors for your health care.  Please think about the main doctor you usually see 
when you are sick or need advice about your health when answering the following questions that 
specifically ask about your medical care or doctor.  [Show patient LIGHT PINK CARD.] 
 
19. How long have you seen your usual doctor?  
0.    UTD 
1.    <1 year 
2.    1 year to less than 3 years 
3.   3 years to less than 5 years 
4.   5 years to less than 10 years 
5.   10 years or more 
 
20. Doctors are good about explaining the reason for medical tests.  
0.    UTD 
1.    Totally agree 
2.    Agree 
3.   Neutral 
4.   Disagree 
5.   Totally disagree 
 
21. I think my doctor’s office has everything needed to provide complete medical care.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
22. The medical care I have been receiving is just about perfect.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
23. Sometimes doctors make me wonder if their diagnosis is correct.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
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5. Totally disagree 
 
24. I feel confident that I can get the medical care I need without being set back financially.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
25. When I go f or m edical car e, t hey are careful t o ch eck everything when t reating an d 
examining me.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
26. I have to pay for more of my medical care than I can afford.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
27. I have easy access to the medical specialists I need.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
28. Where I get medical care, people have to wait too long for emergency treatment.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
29. Doctors act too businesslike and impersonal towards me.  
0.    UTD 
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1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
30. My doctors treat me in a very friendly and courteous manner.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
31. Those who provide my medical care sometimes hurry too much when they treat me.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
32. Doctors sometimes ignore what I tell them.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
33. I have some doubts about the ability of the doctors who treat me.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
34. Doctors usually spend plenty of time with me.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
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35. I find it hard to get an appointment for medical care right away.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
36. I am dissatisfied with some things about the medical care I receive.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
37. I am able to get medical care whenever I need it.  
0.    UTD 
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
PARTICIPATORY DECISION-MAKING STYLE QUESTIONNAIRE 
THE MEDICAL OUTCOMES STUDY (MOS) (D-1) 
 
These next questions are about your participation with your doctor in making decisions about 
your health care.  Again, please think about the main doctor you usually see when you are sick 
or need advice about your health when answering the following questions.  [Show patient BLUE 
CARD.] 
 
38. If there were a choice between treatments, how often would this doctor ask you to help make 
the decision?  
1. Never 
2. Rarely 
3. Occasionally 
4. Very often 
 
39. How often does this doctor give you some control over your treatment?  
1. Never 
2. Rarely 
3. Occasionally 
4. Very often 
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40. How often does this doctor ask you to take some of the responsibility for your treatment?  
1. Never 
2. Rarely 
3. Occasionally 
4. Very often 
 
 
MORISKY SCALE QUESTIONS 
 
These next questions are about how well you stick to taking your medication as directed by your 
doctor. 
 
41. Doctors p rescribe m edications f or m any reasons, s uch a s for cholesterol, bl ood pr essure, 
diabetes, etc.  Has a doctor prescribed for you any medications currently?  
0.   UTD 
1.   Yes 
2.   No 
 
42. Do you currently take medications for any reason?  
0.   UTD 
1.   Yes 
2.   No  SKIP TO QUESTION #94 
 
43. Do you ever forget to take your medications?  
0.   UTD 
1.   Yes 
2.   No 
 
44. Are you ever careless in taking your medications?  
0.   UTD 
1.   Yes 
2.   No 
 
45. Do you ever miss taking your medications when you are feeling better?  
0.   UTD 
1.   Yes 
2.   No 
 
46. Do you ever miss taking your medications because you are feeling sick?  
0.   UTD 
1.   Yes 
2.   No 
 
47. Do you ever miss taking your medication for any reason?  
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0.   UTD 
1. Yes  Specify reason ______________________ 
2.  No 
 
STAGE OF CHANGE QUESTIONS FOR MEDICATION ADHERANCE (Willey, 2000) 
 
48. People sometimes find it difficult to take their medication as directed by their physician. As 
directed means consistently taking the amount of medication prescribed by your physician at 
the t ime(s) prescribed by your physician. Please f ind the statement that best describes the 
way you feel right now about taking your medication as directed.  
 
1. No, I do not take and right now am not considering taking my medication as directed 
(Precontemplation) 
2. No, I do not  t ake but r ight now  am c onsidering t aking m y m edication a s di rected 
(Contemplation) 
3. No, I do  not  t ake but  a m pl anning t o s tart t aking m y m edication as di rected 
(Preparation) 
4. Yes, r ight now  I consistently t ake m y m edication a s di rected. ( Answer que stion 
#48a) 
 
48a. If the answer to previous question is D, then: How long have you taken your medication as 
directed?  
0.    UTD 
1. ≤ 3 months 
2. > 3 months to 6 months 
3. > 6 months to 12 months 
4. > 12 months 
 
 
 
 
MEDICATION ADHERENCE SELF-EFFICACY SCALE IN 
HYPERTENSIVE AFRICAN-AMERICAN PATIENTS (Ogedegbe, 2003) 
 
As we have been discussing, situations come up that make it difficult for people to take their 
medications as prescribed by their doctors.  I will ask you a list of such situations.  I want to 
know your opinion about taking your blood pressure medication(s) under each of them.  Please 
indicate your response by choosing the answer that most closely represents your opinion.  There 
is no right or wrong answer. 
 
For each of the situations listed below, please rate how sure you are that you can take your 
blood pressure medications ALL OF THE TIME.  [Show patient ORANGE CARD.] 
 
49. When you are busy at home  
0.    UTD 
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1. Not at all sure 
2. Somewhat sure 
3. Very sure       … t hat you c an t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
50. When you are at work  
0.    UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
51. When there is no one to remind you  
0.   UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
52. When you worry about taking them for the rest of your life  
0.   UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
53. When they cause some side effects  
0.   UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
54. When they cost a lot of money  
0.    UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
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55. When you come home late from work  
0.    UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
56. When you do not have any symptoms  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
57. When you are with family members  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
58. When you are seen in public places   
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
59. When you are afraid of becoming dependent on them  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
60. When you are afraid they may affect your sexual performance  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
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3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
61. When the time to take them is between your meals  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications all o f th e 
time. 
4. Not applicable 
 
62. When you feel you do not need them  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
63. When you are traveling  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
64. When you take them more than once a day  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
65. If they sometimes make you tired  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
66. If they sometimes make you feel dizzy  
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0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
67. When you have other medications to take  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
68. When you feel well  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that you can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
69. If they make you want to urinate while away from home  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure  …that y ou can t ake your bl ood pr essure m edications a ll of  t he 
time. 
4. Not applicable 
 
Please rate how sure you are that you can carry out the following tasks ALL OF THE TIME. 
 
70. Get refills for your medications before you run out  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure 
4. Not applicable 
 
71. Make taking your medications part of your routine  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure 
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4. Not applicable 
 
 
72. Fill your prescriptions whatever they cost  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure 
4. Not applicable 
 
73. Always remember to take your blood pressure medications  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure 
4. Not applicable 
 
74. Take your blood pressure medications for the rest of your life  
0. UTD 
1. Not at all sure 
2. Somewhat sure 
3. Very sure 
4. Not applicable 
 
BEHAVIOR CHANGE SCALES (Willey, 2005) 
 
For the next set of questions, I will ask you how important each statement is to you in your 
decision to take your medication as directed.  [Show patient TURQUOISE CARD.] 
 
75. When I t ake m y m edications a s di rected, I feel I  am doi ng s omething t o r educe my hi gh 
blood pressure.  
1. Not important 
2. Slightly important 
3. Moderately important 
4. Very important 
5. Extremely important 
 
76. Taking medication as directed makes me feel that my disease is under control.  
1. Not important 
2. Slightly important 
3. Moderately important 
4. Very important 
5. Extremely important 
 
77. When I take my medication as directed, I feel more responsible.  
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1. Not important 
2. Slightly important 
3. Moderately important 
4. Very important 
5. Extremely important 
 
78. Taking medication correctly may prevent high blood pressure symptoms from recurring.  
1. Not important 
2. Slightly important 
3. Moderately important 
4. Very important 
5. Extremely important 
 
79. If I take my medication as directed, I can avoid a possible stroke or heart attack.  
1. Not important 
2. Slightly important 
3. Moderately important 
4. Very important 
5. Extremely important 
 
80. I worry that i t’s unh ealthy t o control m y hi gh b lood pr essure w ith m edication, i nstead o f 
changes in diet, smoking, and exercise.  
1. Not important 
2. Slightly important 
3. Moderately important 
4. Very important 
5. Extremely important 
 
81. Taking too many medications may not be good for my health.  
1. Not important 
2. Slightly important 
3. Moderately important 
4. Very important 
5. Extremely important 
 
82. I worry about the long term effects of taking medication.  
1. Not important 
2. Slightly important 
3. Moderately important 
4. Very important 
5. Extremely important 
 
83. If I take my medications as directed, they will eventually lose their effectiveness.  
1. Not important 
2. Slightly important 
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3. Moderately important 
4. Very important 
5. Extremely important 
 
84. If I take my medication(s) as directed, they will build up to harmful levels in my body over 
time.  
1. Not important 
2. Slightly important 
3. Moderately important 
4. Very important 
5. Extremely important 
 
For each situation I read to you now, select the best response that describes how tempted you 
would be to skip your medication(s) or to take a dose which is different from the one described.  
[Show patient DARK PINK CARD.] 
 
85. When you feel good and think you do not need it.  
1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
 
86. When you are worried about side effects.  
1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
 
87. When you wonder why you need your medication.  
1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
 
88. When you experience minor side effects.  
1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
 
89. When your blood pressure is under control.  
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1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
 
90. When you are asked to come in for additional tests.  
1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
 
91. When the dose of your medication is changed.  
1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
 
92. When the general quality of your life is good.  
1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
 
93. When you have reached your target weight.  
1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
 
94. When you think controlling your blood pressure without medication is better.  
1. Not at all tempted 
2. Slightly tempted 
3. Moderately tempted 
4. Very tempted 
5. Extremely tempted 
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TRUST IN DOCTORS GENERALLY (Hall, et. al, 2002) 
 
The next set of questions deal with patient-physician trust.  These next questions deal with your 
opinion on how you see doctors in general.  [Show patient LIGHT PINK CARD.] 
 
95. Doctors in general care about their patients' health just as much or more than their patients 
do.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
96. Sometimes doc tors care more about what i s convenient for t hem than a bout t heir pa tients’ 
medical needs.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
97. Doctors are extremely thorough and careful.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
98. You completely trust doctors' decisions about which medical treatments are best.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
99. Doctors are totally honest in telling their patients about all of the different treatment options 
available for their conditions.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
100. Doctors think only about what is best for their patients.   
1. Totally agree 
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2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
101. Sometimes doctors do not pay full attention to what patients are trying to tell them.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
102. Doctors always use their very best skill and effort on behalf of their patients.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
103. You have no worries about putting your life in the hands of doctors.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
104. A doctor would never mislead you about anything.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
105. All in all, you trust doctors completely.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
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INTERPERSONAL TRUST IN A PHYSICIAN (Hall, et. al, 2002) 
 
These next questions deal with your opinion about your doctor.  Please think about the main 
doctor you usually see when you are sick or need advice about your health when answering the 
following questions.  [Show patient LIGHT PINK CARD.] 
 
106. [Your doctor] will do whatever it takes to get you all the care you need.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
107. Sometimes [your doctor] cares more about what is convenient for [him/her] than about your 
medical needs.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
108. [Your doctor’s] medical skills are not as good as they should be.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
109. [Your doctor] is extremely thorough and careful.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
110. You completely trust [your doctor's] decisions about which medical treatments are best for 
you.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
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111. [Your doc tor] i s t otally honest i n t elling you a bout a ll of  t he di fferent t reatment opt ions 
available for your condition.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
112. [Your doctor] only thinks about what is best for you.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
113. Sometimes [your doctor] does not pay full attention to what you are trying to tell [him/her].  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
114. You have no worries about putting your life in [your doctor]’s hands.  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
115. All in all, you have complete trust in [your doctor].  
1. Totally agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Totally disagree 
 
MEASURING AFRICAN AMERICANS’ TRUST IN HEALTH CARE (Jacobs 2005) 
 
How true do you think each of the following statements is?  When answering the questions, think 
about things that have happened to you or people you know.  These experiences may be recent or 
in the past.  [Show patient PURPLE CARD.]. 
 
116. Doctors think of themselves before their patient’s well-being.  
1. Never true 
2. A little true 
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3. Half the time true 
4. Mostly true 
5. Always true 
 
117. Doctors do not take the time to explain things in a way that patients can understand.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
118. Doctors care about their patients as people.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
119. Doctors treat their patients without listening to them and examining them.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
120. Doctors in general do not have good bedside manners.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
 
121. Most doctors know how to diagnose and treat their patients.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
122. Doctors s ometimes g ive pe ople m edicine be fore r eally know ing w hat i s w rong w ith t he 
person.  
1. Never true 
2. A little true 
3. Half the time true 
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4. Mostly true 
5. Always true 
 
123. Most doctors are honest with their patients about their illness and treatment.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
124. It is difficult to trust a doctor completely.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
125. Doctors sometimes make mistakes and do not tell their patients.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
126. Doctors do extra tests on patients sometimes to make more money.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
127. Doctors sometimes do n ot do what is best for a patient because it will cost them [doctors] 
money.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
128. Doctors experiment on their patients without telling them.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
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129. In general, doctors treat White patients better than they treat Black patients.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
130. Sometimes doctors treat Black patients with disrespect.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
131. People are often turned away from clinics because they have no insurance.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
132. Hospitals cover up their medical mistakes.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
133. It is hard to trust clinics where the staff is rude.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
134. The front desk staff often assumes Black patients do not have insurance.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
135. Sometimes hospitals experiment on people without telling them.  
1. Never true 
2. A little true 
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3. Half the time true 
4. Mostly true 
5. Always true 
 
136. Hospital clerks will often serve Whites before Blacks.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
137. Sometimes hospital staff is racist.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
138. Clinic staff, in general, is friendlier to Whites than they are to Blacks.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
 
139. Sometimes clinic staff is racist.  
1. Never true 
2. A little true 
3. Half the time true 
4. Mostly true 
5. Always true 
 
 
 
 
DISCRIMINATION QUESTIONNAIRE (CARDIA VI) 
 
Now, I am going to ask you a number of questions about race relations.  Remember that all of 
your answers will remain completely confidential and your answers will in no way affect your 
treatment or care at the hospital. 
 
140. If you feel you have been treated unfairly, do you usually:  (select the best response)  
1. Accept it as a fact of life? 
2. Try to do something about it? 
  
130 
 
 
141. And if you have been treated unfairly, do you usually:  (select the best response)  
1. Talk to other people about it? 
2. Keep it to yourself? 
 
I will read a statement and I want you to either answer "No" or "Yes”.  If you say "Yes", please 
indicate how often you have experienced this (rarely, sometimes, or often). 
 
142. Have you ever experienced discrimination, been prevented from doing something, or been 
hassled or  m ade t o f eel i nferior i n any of  t he f ollowing s even s ituations be cause of  your 
gender? 
  
 142a. At school  2. No 1. Yes  
  If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 142b. Getting a job 2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
  
 142c. Getting housing  2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 
 142d. At work 2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 
 142e. At home 2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
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 142f. Getting medical care 2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 142g. On the street or in  2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
143. Have you ever experienced discrimination, been prevented from doing something, or been 
hassled or made to feel inferior in any of the following seven situations because of your race 
or color? 
  
 143a. At school  2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 
 143b. Getting a job  
   If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 143c. Getting housing  2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 143d. At work  2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
     
 
 143e. At home   2. No 1. Yes  
 If yes, how often 
1. Rarely 
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2. Sometimes 
3. Often 
 
  
 143f. Getting medical care 2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 
  143g. On the street or in  2. No 1. Yes  
 1 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
144. Have you ever experienced discrimination, been prevented from doing something, or been 
hassled or  m ade t o f eel i nferior i n any of  t he f ollowing s even s ituations be cause of  your 
weight? 
  
 144a. At school  2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 144b. Getting a job  2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 
 144c. Getting housing 2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 144d. At work   
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
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 144e. At home  2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 144f. Getting medical care 2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 144g. On the street or in  2. No 1. Yes  
 If yes, how often 
1. Rarely 
2. Sometimes 
3. Often 
 
 
REACTIONS TO RACE (BRFSS) 
 
Now I will ask you some questions about your race. 
 
145. How do other people usually classify you in this country?  Would you say…?  
1. White 
2. Black or African American 
3. Hispanic or Latino 
4. Asian 
5. Native Hawaiian or Other Pacific Islander 
6. American Indian or Alaska Native 
7. Some other group (please specify) ________ 
8. Don’t know / Not sure 
9. Refused 
 
146. How often do you think about your race?  Would you say…? [Instructions to interviewer: 
The responses can be interpreted as meaning “at least” the indicated time frequency.  If a 
respondent cannot decide between two categories, check the response for the lower 
frequency.  For example, if a respondent says that they think about their race between once a 
week and once a month, check “once a month” as the response.]  
1. Never 6. Once an hour 
2. Once a year 7. Constantly 
3. Once a month 8. Don’t know / Not sure 
4. Once a week 9. Refused 
5. Once a day  
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147. Within the past 12 m onths, have you been employed for wages, self-employed, or  out  of 
work for less than one year?  
1. Yes 
2. No  SKIP TO QUESTION #148 
0. UTD 
 
147a. If yes, do you feel you were treated worse than, the same as, or better than people 
of other races?  
  1. Worse than other races 
  2. The same as other races 
  3. Better than other races 
  4. Worse than some races, better than others 
  5. Only encountered people of the same race 
  6. Don’t know / Not sure  
  7. Refused 
  
 
